asgo 2019 presentation type for abstracts …...asgo 2019_presentation type for abstracts submitted...

21
ASGO 2019_Presentation Type for Abstracts Submitted by Oral Category Full Name Country Affiliation 1 OR-0001 Oral Presentation Yuqin Zang China Tianjin Medical University General Hospital 4. Invasive Cervical Cancer Identification of key genes and microRNAs in cervical cancer progression by integrated bioinformatics analysis Oral 2 OR-0002 Oral Presentation Yue Shi China Obstetrics and Gynecology Hospital of Fudan University, Shanghai, P.R. China 7. Endometrial Hyperplasia, EIN and Endometrial Cancer Endocrine hormonal profiles during endometrial cancer development Poster 3 OR-0003 Oral Presentation Qiaoying LYU China obstetrics and gynecology hospital of Fudan university 7. Endometrial Hyperplasia, EIN and Endometrial Cancer Metabolic abnormality of Serum ApoAⅠ Promotes the Development and progression of Endometrial Cancer through Breaking the Immune Homeostasis of tumor Microenvironment Poster Discussion 4 OR-0004 Oral Presentation Kittinun Leetanaporn Thailand Prince of Songkhla University 4. Invasive Cervical Cancer Impact of obesity on clinical outcomes in patients with early-stage cervical cancer after radical hysterectomy with pelvic node dissection Oral 5 OR-0005 Oral Presentation Takashi Mitamura Japan Hokkaido University Hospital 13. Translational Research Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP) Poster Discussion 6 OR-0006 Oral Presentation Haoran Li China Fudan University Shanghai Cancer Center 4. Invasive Cervical Cancer Surgery of Primary Sites for Stage IVB Cervical Cancer Patients Receiving Chemoradiotherapy: A Population- Based Study Poster 7 OR-0007 Oral Presentation Jun Guan China Shanghai OBGYN Hospital of Fudan University 12. Fertility Preservation Effect of Megestrol Acetate plus Metformin as Fertility-Sparing Treatment for Patients with Atypical Endometrial Hyperplasia and Well-differentiated Endometrial Cancer. A Randomized Controlled Trial Oral 8 OR-0008 Oral Presentation Syamel Muhammad Indonesia Andalas University 6. Non-epithelial Ovarian cancer Corelation between tumor size and Neoadjuvant chemotherapy response in Cervical cancer stage IB2 and IIA2 Poster 9 OR-0009 Oral Presentation Syamel Muhammad Indonesia Andalas University 6. Non-epithelial Ovarian cancer Inferior Vena Caval Syndrom in Paraaortic Metastastic Lession of Ovarian Dysgerminoma in Pregnancy Manage with Chemotherapy : a Case Report Poster 10 OR-0010 Oral Presentation Jian AN China Fujian Provincial Maternity and Children’s Hospital 2. Pre-invasive Disease of Uterine Cervix Abnormal endocervical curettage (ECC) result is an independent risk factor of positive margins in conization specimen. Oral 11 OR-0011 Oral Presentation HUMBELINE GABOY Philippines Baguio General Hospital and Medical Center 5. Epithelial Ovarian Cancer MALIGNANT BRENNER TUMOR OF THE OVARY: A CASE REPORT Poster 12 OR-0012 Oral Presentation Saujanya Karmacha rya Nepal IGCS, Civil Service Hospital 3. Pre-invasive Disease and Cancer of Vulvo-Vagina Carcinoma of vulva, case series. Poster 13 OR-0013 Oral Presentation Yang Jie China Peking Union Medical College Hospital 4. Invasive Cervical Cancer Completion hysterectomy after chemoradiotherapy for locally advanced adeno-type cervical carcinoma - updated survival outcomes and experience in post radiation surgery Poster Discussion 14 OR-0014 Oral Presentation Keqi Song China Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University 5. Epithelial Ovarian Cancer Sphingosine kinase 2 inhibitor ABC294640 displays anti-epithelial ovarian cancer activities in vitro and in vivo Oral 15 OR-0015 Oral Presentation Yao Wang China Peking Union Medical College Hospital 1. Cancer Screening Evaluation of cell-free DNA from Papanicolaou smear and peripheral blood to detect endometrial cancer Poster Discussion 16 OR-0016 Oral Presentation Yao Wang China Peking Union Medical College Hospital 9. Genetics Genomic comparison of endometrioid endometrial carcinoma and its precancerous lesions Oral 17 OR-0017 Oral Presentation Zheng Yuan Ng Singapore KK Women's and Children's Hospital 6. Non-epithelial Ovarian cancer Ovarian mass in a patient with a strong history of cancer Poster 18 OR-0018 Oral Presentation Masato Yoshihara Japan Nagoya University 5. Epithelial Ovarian Cancer The effect of pelvic and para-aortic lymphadenectomy for clinically-apparent stage I endometrioid epithelial ovarian carcinoma Oral 20 OR-0020 Oral Presentation Kentaro Ishida Japan Nagahama Red Cross Hospital 5. Epithelial Ovarian Cancer Bevacizumab maintenance therapy extended the overall survival for the histopathological mesenchymal transition type of high-grade serous ovarian carcinoma. Oral 21 OR-0021 Oral Presentation Chel Hun Choi South Korea Samsung Medical Center 4. Invasive Cervical Cancer Phase I Study of a B cell- and Monocyte-based Immunotherapeutic Vaccine, BVAC-C in Human Papillomavirus Type 16- or 18-positive Recurrent Cervical Cancer Poster 22 OR-0022 Oral Presentation Shohei Iyoshi Japan Nagoya University, Department of Obstetrics and Gynecology 5. Epithelial Ovarian Cancer Oncologic outcomes after secondary surgery in recurrent clear-cell carcinoma of the ovary Oral No. Abstract No. Type Author Topic Title Presentation Type

Upload: others

Post on 17-Mar-2020

11 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: ASGO 2019 Presentation Type for Abstracts …...ASGO 2019_Presentation Type for Abstracts Submitted by Oral Category Full Name Country Affiliation 1 OR-0001 Oral Presen ta ion Yuqin

ASGO 2019_Presentation Type for Abstracts Submitted by Oral Category

Full Name Country Affiliation

1 OR-0001 Oral Presentation Yuqin Zang China Tianjin Medical University General Hospital 4. Invasive Cervical Cancer Identification of key genes and microRNAs in cervical cancer progression by integrated bioinformatics analysis Oral

2 OR-0002 Oral Presentation Yue Shi ChinaObstetrics and Gynecology Hospital of Fudan

University, Shanghai, P.R. China7. Endometrial Hyperplasia, EIN and Endometrial Cancer Endocrine hormonal profiles during endometrial cancer development Poster

3 OR-0003 Oral Presentation Qiaoying LYU China obstetrics and gynecology hospital of Fudan university 7. Endometrial Hyperplasia, EIN and Endometrial CancerMetabolic abnormality of Serum ApoAⅠ Promotes the Development and progression of Endometrial Cancer

through Breaking the Immune Homeostasis of tumor MicroenvironmentPoster Discussion

4 OR-0004 Oral Presentation Kittinun Leetanaporn Thailand Prince of Songkhla University 4. Invasive Cervical CancerImpact of obesity on clinical outcomes in patients with early-stage cervical cancer after radical hysterectomy

with pelvic node dissectionOral

5 OR-0005 Oral Presentation Takashi Mitamura Japan Hokkaido University Hospital 13. Translational Research Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP) Poster Discussion

6 OR-0006 Oral Presentation Haoran Li China Fudan University Shanghai Cancer Center 4. Invasive Cervical CancerSurgery of Primary Sites for Stage IVB Cervical Cancer Patients Receiving Chemoradiotherapy: A Population-

Based StudyPoster

7 OR-0007 Oral Presentation Jun Guan China Shanghai OBGYN Hospital of Fudan University 12. Fertility PreservationEffect of Megestrol Acetate plus Metformin as Fertility-Sparing Treatment for Patients with Atypical Endometrial

Hyperplasia and Well-differentiated Endometrial Cancer. A Randomized Controlled TrialOral

8 OR-0008 Oral Presentation Syamel Muhammad Indonesia Andalas University 6. Non-epithelial Ovarian cancer Corelation between tumor size and Neoadjuvant chemotherapy response in Cervical cancer stage IB2 and IIA2 Poster

9 OR-0009 Oral Presentation Syamel Muhammad Indonesia Andalas University 6. Non-epithelial Ovarian cancerInferior Vena Caval Syndrom in Paraaortic Metastastic Lession of Ovarian Dysgerminoma in Pregnancy Manage

with Chemotherapy : a Case ReportPoster

10 OR-0010 Oral Presentation Jian AN China Fujian Provincial Maternity and Children’s Hospital 2. Pre-invasive Disease of Uterine CervixAbnormal endocervical curettage (ECC) result is an independent risk factor of positive margins in conization

specimen.Oral

11 OR-0011 Oral Presentation HUMBELINE GABOY Philippines Baguio General Hospital and Medical Center 5. Epithelial Ovarian Cancer MALIGNANT BRENNER TUMOR OF THE OVARY: A CASE REPORT Poster

12 OR-0012 Oral Presentation Saujanya Karmacha rya Nepal IGCS, Civil Service Hospital 3. Pre-invasive Disease and Cancer of Vulvo-Vagina Carcinoma of vulva, case series. Poster

13 OR-0013 Oral Presentation Yang Jie China Peking Union Medical College Hospital 4. Invasive Cervical CancerCompletion hysterectomy after chemoradiotherapy for locally advanced adeno-type cervical carcinoma -

updated survival outcomes and experience in post radiation surgeryPoster Discussion

14 OR-0014 Oral Presentation Keqi Song ChinaRen Ji Hospital, School of Medicine, Shanghai Jiao

Tong University5. Epithelial Ovarian Cancer Sphingosine kinase 2 inhibitor ABC294640 displays anti-epithelial ovarian cancer activities in vitro and in vivo Oral

15 OR-0015 Oral Presentation Yao Wang China Peking Union Medical College Hospital 1. Cancer Screening Evaluation of cell-free DNA from Papanicolaou smear and peripheral blood to detect endometrial cancer Poster Discussion

16 OR-0016 Oral Presentation Yao Wang China Peking Union Medical College Hospital 9. Genetics Genomic comparison of endometrioid endometrial carcinoma and its precancerous lesions Oral

17 OR-0017 Oral Presentation Zheng Yuan Ng Singapore KK Women's and Children's Hospital 6. Non-epithelial Ovarian cancer Ovarian mass in a patient with a strong history of cancer Poster

18 OR-0018 Oral Presentation Masato Yoshihara Japan Nagoya University 5. Epithelial Ovarian CancerThe effect of pelvic and para-aortic lymphadenectomy for clinically-apparent stage I endometrioid epithelial

ovarian carcinomaOral

20 OR-0020 Oral Presentation Kentaro Ishida Japan Nagahama Red Cross Hospital 5. Epithelial Ovarian CancerBevacizumab maintenance therapy extended the overall survival for the histopathological mesenchymal

transition type of high-grade serous ovarian carcinoma.Oral

21 OR-0021 Oral Presentation Chel Hun Choi South Korea Samsung Medical Center 4. Invasive Cervical CancerPhase I Study of a B cell- and Monocyte-based Immunotherapeutic Vaccine, BVAC-C in Human Papillomavirus

Type 16- or 18-positive Recurrent Cervical CancerPoster

22 OR-0022 Oral Presentation Shohei Iyoshi JapanNagoya University, Department of Obstetrics and

Gynecology5. Epithelial Ovarian Cancer Oncologic outcomes after secondary surgery in recurrent clear-cell carcinoma of the ovary Oral

No. Abstract No. Type

Author

Topic Title Presentation Type

Page 2: ASGO 2019 Presentation Type for Abstracts …...ASGO 2019_Presentation Type for Abstracts Submitted by Oral Category Full Name Country Affiliation 1 OR-0001 Oral Presen ta ion Yuqin

Full Name Country Affiliation

No. Abstract No. Type

Author

Topic Title Presentation Type

23 OR-0023 Oral Presentation Sigit Purbadi IndonesiaUniversity of Indonesia, Dr Ciptomangunkusumo

Hospital5. Epithelial Ovarian Cancer Colororectal and Urologic Surgery in Advanced Ovarian Cancer, Who Should Do It? Poster

24 OR-0024 Oral Presentation Yoshiko Nanki Japan Keio University School of Medicine 5. Epithelial Ovarian Cancer Utility of plasma circulating tumor DNA in ovarian cancer monitoring Poster

25 OR-0025 Oral Presentation Keun Ho Lee South Korea Seoul St. Mary's hospital 15. Surgical Techniques Single-site vs. multiport robotic staging surgery in endometrial cancer Poster

26 OR-0026 Oral Presentation Janice Kwon Canada University of British Columbia 9. GeneticsCost-effectiveness of tumor testing for BRCA mutations in high-grade serous ovarian cancer for PARP inhibitor

maintenance therapyPoster Discussion

27 OR-0027 Oral Presentation Natasha DSouza India P. D. Hiinduja Hospital and Medical Research Centre 5. Epithelial Ovarian Cancer ULTRA-RADICAL SURGERY IN EPITHELIAL OVARIAN CANCER- A SINGLE INSTITUTION EXPERIENCE Poster

28 OR-0028 Oral Presentation Kyungjin Eoh South KoreaDepartment of Obstetrics and Gynecology, Yonsei

University College of Medicine5. Epithelial Ovarian Cancer Mutation Landscape of Germline and Somatic BRCA1/2 genes in High-Grade Serous Ovarian Cancer Patients Oral

29 OR-0029 Oral Presentation Soo Young Jeong South Korea Samsung Medical Center 13. Translational Research Development and preclinical testing of Patient-derived xenograft(PDX) models for uterine cancer Oral

30 OR-0030 Oral Presentation Munekage Yamaguchi Japan Kumamoto University 7. Endometrial Hyperplasia, EIN and Endometrial CancerProlactin enhances the proliferation of endometrial glandular cells and endometrial cancer cells in conjunction

with estradiol via regulation of prolactin receptor and estrogen receptorOral

31 OR-0031 Oral Presentation SungJong Lee South Korea The Catholic University of Korea 2. Pre-invasive Disease of Uterine CervixGX-188E, A THERAPEUTIC HPV VACCINE, IN COMBINATION WITH IMIQUIMOD OR IL-7-HYFC FOR TREATMENT

OF HPV-16 OR HPV-18 RELATED CIN 3: RESULTS FROM PHASE 2 STUDYOral

32 OR-0032 Oral Presentation Kitami Kazuhisa JapanDepartment of Obstetrics and Gynecology, Nagoya

University Graduate School of Medicine12. Fertility Preservation

Oncologic and reproductive outcomes of ovarian cystectomy as a fertility-sparing treatment for early-stage

epithelial ovarian cancer.Poster

33 OR-0033 Oral Presentation Takeshi Motohara Japan Kumamoto University 5. Epithelial Ovarian Cancer Ovarian cancer stemness: biological and clinical implications for ovarian cancer metastasis and chemoresistance Poster

34 OR-0034 Oral Presentation Alexander Shushkevich Belarus N.N.Alexandrov Cancer Center of Belarus 7. Endometrial Hyperplasia, EIN and Endometrial Cancer Stage one endometrial cancer. Concept extensions of risk group. Poster

35 OR-0035 Oral Presentation Hiroko Machida Japan Tokai University School of Medicine 5. Epithelial Ovarian Cancer Trends and characteristics of epithelial ovarian cancer between Japan and the US: A JSGO?JSOG joint study Poster

36 OR-0036 Oral Presentation Weiping Wang China

Peking Union Medical College Hospital, Chinese

Academy of Medical Sciences & Peking Union Medical

College

4. Invasive Cervical CancerPosttreatment squamous cell carcinoma antigen in predicting treatment failure in patients with cervical

squamous cell carcinoma treated with concurrent chemoradiotherapyPoster Discussion

37 OR-0037 Oral Presentation Feng liyuan ChinaAffiliated Tumor Hospital of Guangxi Medical

University5. Epithelial Ovarian Cancer Investigate the effect of RDX and ITGA5 on platinum resistance in ovarian cancer. Poster

38 OR-0038 Oral Presentation Feng liyuan ChinaAffiliated Tumor Hospital of Guangxi Medical

University5. Epithelial Ovarian Cancer The risk factors, risk assessment and prognosis in Gynecology oncology patients with thromboembolism Poster

39 OR-0039 Oral Presentation Weijuan Xin ChinaObstetrics and Gynecology Hospital of Fudan

University7. Endometrial Hyperplasia, EIN and Endometrial Cancer

LncRNA RP11-395G23.3, as a competitive endogenous RNA, regulate PTEN expression by sponging miR-205-5p

in the progression of Endometrial CancerOral

40 OR-0040 Oral Presentation feng liyuan ChinaAffiliated Tumor Hospital of Guangxi Medical

University5. Epithelial Ovarian Cancer

Potential methylation diagnostic markers related to platinum-based chemotherapy sensitivity in epithelial ovarian

cancerPoster Discussion

41 OR-0041 Oral Presentation feng liyuan ChinaThe Affiliated Tumor Hospital of Guangxi Medical

University5. Epithelial Ovarian Cancer

LIPG/rs9958734 and VPS13A/rs7034531, new therapeutic targets for reversing multidrug resistance in epithelial

ovarian cancerPoster Discussion

42 OR-0042 Oral Presentation Feng Liyuan China Guangxi Medical University 4. Invasive Cervical Cancer Clinical pathological analysis and prognosis prediction model of small cell carcinoma of the cervix Oral

43 OR-0043 Oral Presentation Xiaoliang Liu China

Department of Radiation Oncology, Peking Union

Medical College Hospital, Chinese Academy of Medical

Science & Peking Union Medical College

4. Invasive Cervical CancerA Risk Stratification for Patients with Cervical Cancer in Stage IIIC1 of the 2018 FIGO Staging System Treated

with Definitive ChemoradiotherapyPoster Discussion

44 OR-0044 Oral Presentation Danian Dai China The Fifth Affiliated Hospital of Sun Yat-Sen University 5. Epithelial Ovarian CancerImpact on Overall Survival of Non-Specific Death in Early-Stage Epithelial Ovarian Cancer Patients: A SEER

Database AnalysisPoster Discussion

Page 3: ASGO 2019 Presentation Type for Abstracts …...ASGO 2019_Presentation Type for Abstracts Submitted by Oral Category Full Name Country Affiliation 1 OR-0001 Oral Presen ta ion Yuqin

Full Name Country Affiliation

No. Abstract No. Type

Author

Topic Title Presentation Type

45 OR-0045 Oral Presentation Lanzhou Jiao China

Dalian Maternal and Child Health Care Hospital &

Dalian Obstetrics and Gynecology Hospital affiliated to

Dalian Medical University

8. Rare Tumors including Uterine Sarcoma & GTDClinical significance of centralized surveillance of hydatidiform mole: five years' experience from a regional

hospital in ChinaOral

47 OR-0047 Oral Presentation Keng Shen China Peking Union Medical College Hospital 10. Quality of LifePiver type II versus type III hysterectomy in the treatment of early-stage cervical cancer: midterm follow-up

results of a randomized controlled trialPoster Discussion

48 OR-0048 Oral Presentation Weiping Wang China

Department of radiation oncology, Peking Union

Medical College Hospital. Chinese Academy of Medical

Sciences & Peking Union Medical College

4. Invasive Cervical Cancer Indications of prophylactic extended-field irradiation for patients with cervical cancer Oral

49 OR-0049 Oral Presentation Weiping Wang China

Department of radiation oncology, Peking Union

Medical College Hospital. Chinese Academy of Medical

Sciences & Peking Union Medical College

4. Invasive Cervical CancerProphylactic extended-field irradiation can improve the disease-free survival of cervical cancer patients with risk

factorsPoster

50 OR-0050 Oral Presentation Fitriyadi Kusuma Djajasasmita Indonesia

Obstetrics and Gynecology Department Faculty of

Medicine Universitas Indonesia/Dr. Cipto

Mangunkusumo General Hospital Jakarta, Indonesia

4. Invasive Cervical CancerComparisons of Radiotherapy Outcomes in Cervical Squamous Cell Carcinoma Stage IIIB with and without

Lymph Node EnlargementOral

51 OR-0051 Oral Presentation Eiko Aoki Japan

Department of Preventive Medicine Center,

International University of Health and Welfare, Mita

Hospital

1. Cancer ScreeningDifferences in the results of evaluation of quality assurance between the two methods of provision of

population-based cervical cancer screening in JapanOral

52 OR-0052 Oral Presentation Xuewei Zhang Japan

Department of Obstetrics and Gynecology, Tohoku

University Graduate School of Medicine, Tohoku

University

5. Epithelial Ovarian CancerTyrosine kinase receptor TIE-1 mediates cell growth by regulating PI3K/Akt signaling pathway in PI3K-high-

expressing ovarian cancer.Oral

53 OR-0053 Oral Presentation Chao Gao China Tianjin Medical University General Hospital, Tianjin 7. Endometrial Hyperplasia, EIN and Endometrial CancerInactivating mutations of the IK gene inhibit endometrial cancer progression through regulating mitosis and

non-homologous end joining DNA repair pathwayPoster

54 OR-0054 Oral Presentation Saki Ishii Japan Sakai City Medical Center 6. Non-epithelial Ovarian cancer A case of ovarian mixed germ cell tumor with torsion Poster

55 OR-0055 Oral Presentation Mi Kyoung Kim South KoreaDepartment of Obstetrics & Gynecology, CHA

Gangnam Medical Center, CHA University, Seoul7. Endometrial Hyperplasia, EIN and Endometrial Cancer

Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with

progestin for endometrial hyperplasia: A Korean Gynecologic Oncology Group StudyOral

56 OR-0056 Oral Presentation Zhimin Liu China Sun Yat-sen University 4. Invasive Cervical Cancer clear cell adenocarcinoma of the uterine cervix: a larger sample retrospective study Poster

57 OR-0057 Oral Presentation Xuan Zong China

Peking Union Medical College Hospital, Chinese

Academy of Medical Sciences and Peking Union

Medical College

6. Non-epithelial Ovarian cancer Genetic profiling and clonal evolution in ovarian yolk sac tumor Poster Discussion

58 OR-0058 Oral Presentation Hiroshi Asano Japan

Department of Obstetrics and Gynecology, Faculty of

Medicine and Graduate School of Medicine, Hokkaido

University

5. Epithelial Ovarian CancerLow expression of gamma-glutamyl transpeptidase 1 is an independent poor prognostic factor associated with

up-regulation of immune suppressive genes and EMT-related genes in ovarian clear cell carcinomaOral

59 OR-0059 Oral Presentation Xiaodan Mao ChinaFujian Provincial Maternity and Children’s Hospital,

affiliated hospital of Fujian Medical University7. Endometrial Hyperplasia, EIN and Endometrial Cancer

Dual targeting of estrogen receptor α and estrogen-related receptor α: A novel endocrine therapy for

endometrial cancerPoster

60 OR-0060 Oral Presentation Haifeng Lin ChinaFujian Provincial Maternity and Children's Hospital,

Affiliated Hospital of Fujian Medical University2. Pre-invasive Disease of Uterine Cervix Co-infection of high-risk human papillomavirus and lower genital tract pathogens in women with cervical lesions Poster

61 OR-0061 Oral Presentation Patel Viral India Amrita Institute of Medical Science, Kochi 7. Endometrial Hyperplasia, EIN and Endometrial CancerComparison of sentinel lymphnode detection rate in endometrial carcinoma using Indocyanine green fluorescent

dye versus Indocyanine green with 99m Technetium (99m Tc) Sulphur colloidPoster

62 OR-0062 Oral Presentation Dong Binhua ChinaFujian Provincial Maternity and Children’s Hospital,

Affiliated Hospital of Fujian Medical University1. Cancer Screening

Evaluation of high-risk human papillomavirus genotyping and non-genotyping assays for cervical cancer

screening, a real-world study in ChinaPoster

63 OR-0063 Oral Presentation Lihua Chen ChinaFujian Provincial Maternity and Children’s Hospital,

affiliated hospital of Fujian Medical University4. Invasive Cervical Cancer

Baseline Human Papillomavirus Viral Load as a Predictor of Post-Treatment Recurrence or Residual Disease for

High-Grade Cervical Intraepithelial NeoplasiaPoster Discussion

64 OR-0064 Oral Presentation Menglei Zhang ChinaObstetrics and Gynecology Hospital of Fudan

University5. Epithelial Ovarian Cancer The Factors Predicting Lymph Node Metastasis in Patients with Borderline Ovarian Tumor Poster

65 OR-0065 Oral Presentation Xiaoliang Liu China

Peking Union Medical College Hospital, Chinese

Academy of Medical Sciences & Peking Union Medical

College

4. Invasive Cervical CancerValidation of the 2018 FIGO Staging System of Cervical Cancer for Stage III Patients with a Single-Center Cohort

from ChinaPoster

66 OR-0066 Oral Presentation hyun woong cho South Korea Korea University Guro Hospital 2. Pre-invasive Disease of Uterine CervixThe risk of high-grade cervical intraepithelial neoplasia (CIN) and cancer in patients aged 65 years or older with

abnormal cervical cancer screening testPoster

67 OR-0067 Oral Presentation Jun Li ChinaObstetrics and Gynecology Hospital of Fudan

University 5. Epithelial Ovarian Cancer SNAI2 3'untrasnlated region promotes the invasion of ovarian cancer cells by inducing MARCKS expression Poster

Page 4: ASGO 2019 Presentation Type for Abstracts …...ASGO 2019_Presentation Type for Abstracts Submitted by Oral Category Full Name Country Affiliation 1 OR-0001 Oral Presen ta ion Yuqin

Full Name Country Affiliation

No. Abstract No. Type

Author

Topic Title Presentation Type

68 OR-0068 Oral Presentation Jun Li ChinaObstetrics and Gynecology Hospital of Fudan

University 5. Epithelial Ovarian Cancer

Development and validation of SIRT3-related nomogram predictive of overall survival in patients with serous

ovarian cancerPoster

69 OR-0069 Oral Presentation Jieyu Wang China Obstetrics and Gynecology Hospital, Fudan University 5. Epithelial Ovarian Cancer The role and regulatory mechanism of CHD4 in epithelial ovarian cancer Poster

70 OR-0070 Oral Presentation Jieyu Wang China Obstetrics and Gynecology Hospital, Fudan University 6. Non-epithelial Ovarian cancerIndividualized significance of lymphadenectomy across all age groups and histologies in malignant ovarian germ

cell tumorsPoster

71 OR-0071 Oral Presentation Se Ik Kim South Korea

Department of Obstetrics and Gynecology, Seoul

National University College of Medicine, Seoul,

Republic of Korea

2. Pre-invasive Disease of Uterine CervixDiagnostic inaccuracy of colposcopy-directed biopsy in women with cytologic high-grade squamous

intraepithelial lesion: immediate loop electrosurgical excision procedure may be a better strategyPoster

72 OR-0072 Oral Presentation Seob Jeon South Korea Soonchunhyang university Cheonan hospital 13. Translational ResearchDoxorubicin-loaded oligonucleotide conjugated gold nanoparticles: a promising drug delivery system for ovarian

cancerOral

73 OR-0073 Oral Presentation Ting Wang ChinaDepartment of Gynecology, Obstetrics and Gynecology

Hospital, Fudan University8. Rare Tumors including Uterine Sarcoma & GTD

Clear cell adenocarcinoma of the cervix: an analysis of clinicopathological characteristics and introspection on

radical surgical treatmentPoster

74 OR-0074 Oral Presentation Ting Wang ChinaDepartment of Gynecology, Obstetrics and Gynecology

Hospital, Fudan University7. Endometrial Hyperplasia, EIN and Endometrial Cancer Comparison and analysis of the clinicopathological features of SCEO and ECOM Poster

75 OR-0075 Oral Presentation Yung-Taek Ouh South Korea Korea University Guro Hospital 2. Pre-invasive Disease of Uterine CervixRisk factors for type-specific persistence of human papillomavirus and recurrence of cervical intraepithelial

neoplasia after conizationOral

76 OR-0076 Oral Presentation Gladdy Maura Facun Philippines Philippine General Hospital 7. Endometrial Hyperplasia, EIN and Endometrial CancerWhen Everything Turns to Black - MAN: A Sign of Impending Doom;;;; Malignant Acanthosis Nigricans (MAN) in

a Patient with Endometrial CarcinomaPoster

77 OR-0077 Oral Presentation Gladdy Maura Facun Philippines Philippine General Hospital 11. Supportive Care Knowledge, Attitude and Practices of Gynecologists in a Tertiary Hospital on Preoperative Bowel Preparation Oral

78 OR-0078 Oral Presentation Ji-Hyun Jang Canada The University of British Columbia 10. Quality of Life Hormone Replacement Therapy After Premature Surgical Menopause and Health Services Utilization Oral

79 OR-0079 Oral Presentation Hyun Woong Cho South Korea Korea University Guro Hospital 3. Pre-invasive Disease and Cancer of Vulvo-Vagina The risk factors of high-grade vaginal intraepithelial neoplasia (VaIN) and cancer: Single institution experience Poster

80 OR-0080 Oral Presentation Yung-Taek Ouh South Korea Korea University Guro Hospital 2. Pre-invasive Disease of Uterine Cervix Cervical intraepithelial neoplasia and risk of gynecologic cancer: A nationwide cohort study Poster

81 OR-0081 Oral Presentation Jung-Yun Lee South Korea Yonsei University 14. Clinical trials, Trials in ProgressAn umbrella study of biomarker-driven targeted therapy in patients with platinum-resistant recurrent ovarian

cancer:Poster

82 OR-0082 Oral Presentation KOHEI YAMAGUCHI Japan The University of Tokyo 4. Invasive Cervical CancerEnhanced chemotherapy effects on gynecological cancers by using the combination of lipid bubble and

ultrasoundOral

84 OR-0084 Oral Presentation Honglan Honglan China Peking University 8. Rare Tumors including Uterine Sarcoma & GTDUterine smooth muscle tumors of uncertain malignant potential (STUMP): a clinicopathologic analysis of 29

casesPoster

85 OR-0085 Oral Presentation Tofan Utami Indonesia FMUI 5. Epithelial Ovarian Cancer Creatinin Clearance vs Glomerular Filtration Rate in Platinum Based Chemotherapy: Which One is The Best? Poster

86 OR-0086 Oral Presentation Zhengmao Zhang China The fourth hospital of hebei medical university 4. Invasive Cervical CancerSentinel lymph nodes mapping can predict the state of peritoneal lymph nodes metastasis in early-stage cervical

cancerPoster

87 OR-0087 Oral Presentation Junchen Chen China Peking University People’s Hospital, Beijing, China 5. Epithelial Ovarian Cancer Risk factors for severe postoperative morbidity and specific complications for advanced ovarian cancer Poster

88 OR-0088 Oral Presentation Junchen Chen China Peking University People’s Hospital, Beijing, China 5. Epithelial Ovarian Cancer Preoperative low hematocrit is an adverse prognostic biomarker in ovarian cancer Poster

89 OR-0089 Oral Presentation Junchen Chen China Peking University People’s Hospital, Beijing, China 5. Epithelial Ovarian CancerA preoperative risk score to predict intraoperative blood loss volume in patients undergoing hysterectomy for

ovarian cancerPoster

90 OR-0090 Oral Presentation Huan Yi ChinaFujian Provincial Maternity and Children’s Hospital,

Affiliated Hospital of Fujian Medical University8. Rare Tumors including Uterine Sarcoma & GTD

Hysteroscopy versus curettage for nonmetastatic post-molar gestational trophoblastic neoplasia: a retrospective

review of two medical centers in Fujian Province, ChinaPoster

Page 5: ASGO 2019 Presentation Type for Abstracts …...ASGO 2019_Presentation Type for Abstracts Submitted by Oral Category Full Name Country Affiliation 1 OR-0001 Oral Presen ta ion Yuqin

Full Name Country Affiliation

No. Abstract No. Type

Author

Topic Title Presentation Type

91 OR-0091 Oral Presentation Huan Yi ChinaFujian Provincial Maternity and Children’s Hospital,

Affiliated Hospital of Fujian Medical University5. Epithelial Ovarian Cancer

Lipolysis stimulated lipoprotein receptor down-regulates CD8+ T cells and promotes invasion and metastasis of

ovarian cancerPoster

92 OR-0092 Oral Presentation Jung-Yun Lee South Korea Yonsei University 14. Clinical trials, Trials in ProgressA phase II study of Neoadjuvant chemotherapy plus Durvalumab (MEDI4736) and Tremelimumab in Advanced-

stage ovarian cancer:Poster

93 OR-0093 Oral Presentation R RAJAGOPALAN R IndiaBASAVATARAKAM INDO-AMERICAN CANCER

HOSPITAL AND RESEARCH INSTITUTE15. Surgical Techniques LAPAROSCOPIC RETROPERITONEAL LYMPHADENECTOMY Poster

94 OR-0094 Oral Presentation Yudi Mulyana Hidayat Indonesia

Department of Obstetrics and Gynecology, Faculty of

Medicine, Padjadjaran University / Dr. Hasan Sadikin

General Hospital, Bandung, Indonesia

5. Epithelial Ovarian Cancer The Role Of Akt2, and CA-125 Serum Levels As Predictors For Cytoreduction In Epithelial Ovarian Cancer Surgery Oral

95 OR-0095 Oral Presentation Jeong-Won Lee South Korea Samsung Medical Center 5. Epithelial Ovarian Cancer Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers Oral

96 OR-0096 Oral Presentation Dipanwita Banerjee India Chittaranjan National Cancer Institute 1. Cancer ScreeningA PROSPECTIVE RANDOMIZED CONTROLLED STUDY TO COMPARE THERMAL ABLATION WITH CRYOTHERAPY

IN CERVICAL CANCER SCREENINGOral

97 OR-0097 Oral Presentation E Sun Paik South Korea

Department of Obstetrics and Gynecology, Samsung

Medical Center, Sungkyunkwan University School of

Medicine, Seoul, Korea

4. Invasive Cervical CancerComparison of laparoscopic and abdominal radical hysterectomy in early stage cervical cancer patients without

adjuvant treatment: Ancillary analysis of A Korean Gynecologic Oncology Group Study (KGOG 1028)Poster

98 OR-0098 Oral Presentation Jung-Yun Lee South Korea Yonsei University 14. Clinical trials, Trials in ProgressComparative Effectiveness of HIPEC Following Interval Debulking Surgery in Patients With Advanced-stage

Ovarian Cancer: KGOG 3042Poster

99 OR-0099 Oral Presentation Jung-Yun Lee South Korea Yonsei University 14. Clinical trials, Trials in ProgressA phase II trial to evaluate the efficacy of Bortezomiab and Pegylated liposomal doxorubicin in patients with

BRCA wild type platinum-resistant recurrent ovarian cancer: KGOG 3044, EBLINPoster

100 OR-0100 Oral Presentation Rui-fang Chen ChinaObstetrics and Gynecology Hospital of Fudan

University5. Epithelial Ovarian Cancer

A clinicopathologic multivariate analysis in effects of Intraepithelial Carcinoma on patients with Mucinous

Borderline Ovarian TumorsPoster

101 OR-0101 Oral Presentation Joo-Hyuk Son South Korea Ajou University School of Medicine 5. Epithelial Ovarian CancerPrognostic analysis of splenic parenchymal metastasis in advanced ovarian cancer: Does the parenchymal

metastasis matter ?Poster

102 OR-0102 Oral Presentation Joo-Hyuk Son South Korea Ajou University School of Medicine 5. Epithelial Ovarian Cancer Safety and feasibility of preemptive cholecystectomy as part of cytoreductive surgery in advanced ovarian cancer Poster

103 OR-0103 Oral Presentation Shuang Zhou ChinaObstetrics and Gynecology Hospital of Fudan

University12. Fertility Preservation

Characteristics and Therapeutic Effects for Progestin-resistant Early Endometrial Cancer and Atypical Hyperplasia

Patients Receiving Fertility-sparing TreatmentPoster

104 OR-0104 Oral Presentation Kyungjin Eoh South KoreaDepartment of Obstetrics and Gynecology, Yonsei

University College of Medicine4. Invasive Cervical Cancer

Single Port Access Laparoscopic Radical Hysterectomy for Early-Stage Cervix Cancer Running title: SPA LRH for

cervical cancerPoster

105 OR-0105 Oral Presentation Won Kyung Cho South Korea

Department of Radiation Oncology, Samsung Medical

Center, Sungkyunkwan University School of Medicine,

Seoul

4. Invasive Cervical CancerPrognosis of stage IIIC uterine cervical cancer following hysterectomy and radiotherapy: validation of revised

FIGO stagingPoster

106 OR-0106 Oral Presentation Chih-Ming Ho Taiwan

Gynecologic Cancer Center, Department of Obstetrics

and Gynecology, Cathay General Hospital, Taipei,

Taiwan

5. Epithelial Ovarian CancerDifferential Promoter Methylation and Expression at RASSF1A Between Ovarian Carcinoma Stromal Progenitor

and Cancer Cells Predict Survival Outcome of Epithelial Ovarian Cancer PatientsPoster

107 OR-0107 Oral Presentation Xiaohua Wu ChinaDepartment of Gynecologic Oncology, Fudan

University Shanghai Cancer Center14. Clinical trials, Trials in Progress

A Multi-Center, Double-Blind, Randomized, Placebo-controlled Phase III Clinical Study Evaluating Niraparib as

Maintenance Therapy in Chinese Patients with Platinum-Sensitive, Recurrent Ovarian CancerPoster

108 OR-0108 Oral Presentation Xiaohua Wu ChinaDepartment of Gynecologic Oncology, Fudan

University Shanghai Cancer Center5. Epithelial Ovarian Cancer

A prospective evaluation of tolerability of niraparib dosing based on baseline body weight and platelet count:

Blinded pooled interim safety data from the NORA StudyPoster

109 OR-0109 Oral Presentation Mi-Kyung Kim South Korea Ewha Womans University 7. Endometrial Hyperplasia, EIN and Endometrial Cancer Clinicopathologic significance of mismatch repair protein expression in endometrial cancer Oral

110 OR-0110 Oral Presentation Ye Lee Yu South Korea National Cancer Center 10. Quality of LifeThe influence of depression on health utility value in patients with gynecologic cancer : A comparison with

physical symptoms and performance statusOral

111 OR-0111 Oral Presentation Ye Lee Yu South Korea National Cancer Center 11. Supportive Care Fear of receiving less effective care: A barrier to effective cancer care cost communication Poster

112 OR-0112 Oral Presentation Ye Lee Yu South Korea National Cancer Center 10. Quality of Life Are we ready for the increasing burden of cancer care cost? A willing-to-pay analysis Poster

Page 6: ASGO 2019 Presentation Type for Abstracts …...ASGO 2019_Presentation Type for Abstracts Submitted by Oral Category Full Name Country Affiliation 1 OR-0001 Oral Presen ta ion Yuqin

Full Name Country Affiliation

No. Abstract No. Type

Author

Topic Title Presentation Type

113 OR-0113 Oral Presentation Hyun Jin Choi South Korea

Department of Obstetrics and Gynecology, Chung-Ang

University College of Medicine, Seoul, Republic of

Korea

4. Invasive Cervical CancerTriplet Chemotherapy versus Doublet Chemotherapy Plus Bevacizumab in Metastatic, Recurrent, and Persistent

Cervical CancerPoster

114 OR-0114 Oral Presentation Tae-Wook Kong South Korea Ajou University Hospital 7. Endometrial Hyperplasia, EIN and Endometrial CancerRisk factors for lymph node metastasis in FIGO stage I-IIIC endometrioid carcinoma according to lymphovascular

space invasionOral

115 OR-0115 Oral Presentation Ling Lim Taiwan MacKay Memorial Hospital, Taipei, Taiwan 5. Epithelial Ovarian Cancer Modulation of Tumor Microenironment by Chemotherapy in Ovarian Cancer Poster

116 OR-0116 Oral Presentation Tae-Wook Kong South Korea Ajou University Hospital 7. Endometrial Hyperplasia, EIN and Endometrial CancerSurvival outcomes of FIGO stage IIIC and IVB endometrial cancer patients presenting primarily as nodal spreads

without peritoneal carcinomatosisPoster

117 OR-0117 Oral Presentation Jianwen Gao ChinaDepartment of Health Science, Graduate School of

Medical, Osaka University, Osaka, Japan5. Epithelial Ovarian Cancer Rosiglitazone ameliorates senescence-like phenotypes in ovarian cancer Poster Discussion

118 OR-0118 Oral Presentation Fangyue Zhou ChinaObstetrics and Gynecology Hospital of Fudan

University3. Pre-invasive Disease and Cancer of Vulvo-Vagina Types and Viral Load of Human Papillomavirus in Vaginal Intraepithelial Neoplasia: A Cross-section Study Poster

120 OR-0120 Oral Presentation Fangyue Zhou ChinaObstetrics and Gynecology Hospital of Fudan

University3. Pre-invasive Disease and Cancer of Vulvo-Vagina A case-control Study of the Association between Vaginal Microbiota and Vaginal Lesions Poster

121 OR-0121 Oral Presentation Se Ik Kim South KoreaDepartment of Obstetrics and Gynecology, Seoul

National University College of Medicine4. Invasive Cervical Cancer

Impact of laparoscopic radical hysterectomy on survival outcome in patients with FIGO stage IB cervical cancer:

A matching study of two institutional hospitals in KoreaPoster

122 OR-0122 Oral Presentation Shuang Ye China Fudan University Shanghai Cancer Center 14. Clinical trials, Trials in Progress Clinical Trials in Ovarian Clear Cell Carcinoma Poster

123 OR-0123 Oral Presentation Youngjae Lee South Korea Asan Medical Center 5. Epithelial Ovarian CancerComparison of ROMA algorithm and CA 125 as tools for discriminate benign ovarian tumor and early stage

ovarian cancer according to imaging tumor subtypes that connected to postoperative histopathologic findingsOral

124 OR-0124 Oral Presentation Yusuke Kobayashi JapanDepartment of Obstetrics and Gynecology, Keio

University School of Medicine4. Invasive Cervical Cancer Prognosis of early-stage neuroendocrine carcinomas of the cervix: study at a Japanese single institute Poster

125 OR-0125 Oral Presentation HYEONGIN HA South KoreaResearch Institute and Hospital, National Cancer

Center, Goyang, Korea.9. Genetics

Reclassification of BRCA1 and BRCA2 Variants of Uncertain Significance in Ovarian Epithelial, Fallopian Tube, and

Primary Peritoneal CancerPoster

126 OR-0126 Oral Presentation Soojin Park South Korea Seoul National University Hospital 5. Epithelial Ovarian CancerSurvival impact of complete resection of supradiaphragmatic lymph nodes in advanced ovarian cancer for

optimal cytoreductionOral

127 OR-0127 Oral Presentation Mengpei Zhang ChinaWest China Second University Hospital, Sichuan

University1. Cancer Screening The distribution and prevalence of high-risk human papillomavirus of women in western China: A meta-analysis Oral

128 OR-0128 Oral Presentation Anyue Wu China

Department of Obstetrics and Gynecology, Ren Ji

Hospital, School of Medicine, Shanghai JiaoTong

University, Shanghai, China

2. Pre-invasive Disease of Uterine CervixTopical photodynamic therapy with 5-aminolevulinic acid in the treatment of cervical low grade squamous

intraepithelial lesionPoster

129 OR-0129 Oral Presentation Jun Hyeok KANG South Korea

Department of Obstetrics and Gynecology, Samsung

Medical Center, Sungkyunkwan University School of

Medicine, Seoul, Korea

14. Clinical trials, Trials in ProgressA multicenter phase I/IIa study of BVAC-C in patients with multiple metastatic progress or recurrent HPV 16 or

18 positive cervix cancer after fail to standard carePoster

130 OR-0130 Oral Presentation Lingying Wu China

Department of Gynecologic Oncology, National Cancer

Center/National Clinical Research Center for

Cancer/Cancer Hospital, Chinese Academy of Medical

14. Clinical trials, Trials in Progress

A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial Evaluating Niraparib as 1st-

line Maintenance Therapy in Patients with Advanced Ovarian Cancer Following Response to Front-line Platinum-

based Chemotherapy (PRIME study)

Poster

131 OR-0131 Oral Presentation Meimei Huang China the first name 6. Non-epithelial Ovarian cancer Clinicopathological data analysis of 164 patients Poster

132 OR-0132 Oral Presentation Moito Iijima Japan

Department of Obstetrics and Gynecology, Keio

University School of Medicine;; Radiation and Cancer

Biology Team, National Institute of Radiological

4. Invasive Cervical CancerPost-irradiation PD-L1 expression predicts better prognosis after carbon ion radiotherapy in uterine cervical

adenocarcinomaOral

133 OR-0133 Oral Presentation Jun Li China Obstetrics and Gynecology Hospital, Fudan University 8. Rare Tumors including Uterine Sarcoma & GTDChemotherapy for gestational trophoblastic neoplasia patients with a FIGO score of 12 or greater: a multistudy

analysisPoster

134 OR-0134 Oral Presentation Takashi Takeda Japan

Department of Obstetrics and Gynecology, Keio

University School of Medicine, Department of

Translational Oncology, National Cancer Center

13. Translational ResearchTargeting casein kinase 2 disrupts intracellular trafficking of IGF2R and lysosomal homeostasis and induced cell

death in cervical cancerPoster

135 OR-0135 Oral Presentation Xin Lu China Obstetrics and Gynecology Hospital, Fudan University 8. Rare Tumors including Uterine Sarcoma & GTDCentralized management of gestational trophoblastic neoplaisa: experience from a single tertiary center in

Shanghai, ChinaPoster

Page 7: ASGO 2019 Presentation Type for Abstracts …...ASGO 2019_Presentation Type for Abstracts Submitted by Oral Category Full Name Country Affiliation 1 OR-0001 Oral Presen ta ion Yuqin

Full Name Country Affiliation

No. Abstract No. Type

Author

Topic Title Presentation Type

136 OR-0136 Oral Presentation Aswathy G Nath India RCC, Thiruvananthapuram, India 7. Endometrial Hyperplasia, EIN and Endometrial CancerFEASIBILITY OF SENTINEL LYMPH NODE SAMPLING IN EARLY STAGE CARCINOMA ENDOMETRIUM :

EXPERIENCE FROM A DEVELOPING COUNTRYPoster

137 OR-0137 Oral Presentation Yasuhiko Shiki Japan Osaka Rosai Hospital 4. Invasive Cervical CancerMeasures to prevent tumor spillage in laparoscopic surgery and outcome of total laparoscopic and abdominal

radical hysterectomy for FIGO 1B1-2 cervical cancerPoster

138 OR-0138 Oral Presentation Man Yee Chu Hong Kong Queen Mary Hospital, The University of Hong Kong 7. Endometrial Hyperplasia, EIN and Endometrial Cancer Long Term Outcome of Young Patients with Mismatch-Repair Deficient Endometrial Carcinoma Oral

139 OR-0139 Oral Presentation Yi Liang ChinaDepartement of gynecology and obstetric nursing,

nursing school of Peking university10. Quality of Life The Effects of ERAS programs in Patients with Gynecological malignancy: a Meta-analysis and Systematic Review Poster

140 OR-0140 Oral Presentation Guannan Zhou ChinaDepartment of Gynecology, the Obstetrics and

Gynecology Hospital of Fudan University6. Non-epithelial Ovarian cancer

Resibufogenin inhibits ovarian clear cell carcinoma (OCCC) growth in vivo, and migration of OCCC cells in vitro,

by down-regulating the PI3K/AKT and actin cytoskeleton signaling pathwaysPoster

141 OR-0141 Oral Presentation Guannan Zhou ChinaDepartment of Gynecology, the Obstetrics and

Gynecology Hospital of Fudan University15. Surgical Techniques

The role of oral oil administration in displaying the chylous tubes and preventing chylous leakage in

laparoscopic para-aortic lymphadenectomy in gynecologic surgeriesPoster

142 OR-0142 Oral Presentation Guannan Zhou ChinaDepartment of Gynecology, the Obstetrics and

Gynecology Hospital of Fudan University5. Epithelial Ovarian Cancer

Engineered bovine-milk-exosome-mediated delivery of resibufogenin and its enhanced suppression effect in

platinum-resistant ovarian cancer cellsPoster

143 OR-0143 Oral Presentation Beibei Wu ChinaObstetrics and Gynecology Hospital of Fudan

University5. Epithelial Ovarian Cancer

The comparative analysis of clinicopathologic characteristics between Seromucinous Borderline Ovarian Tumors

(SMBOTs) and Mucinous Borderline Ovarian Tumors (MBOTs)Poster

144 OR-0144 Oral Presentation Huiran Yue China Obstetrics and Gynecology Hospital, Fudan University 5. Epithelial Ovarian CancerGene signature characteristic of elevated stromal infiltration and activation is associated with increased risk of

hematogenous and lymphatic metastasis in serous ovarian cancerPoster

145 OR-0145 Oral Presentation YING LI ChinaWomen's Hospital, School of Medicine, Zhejiang

University1. Cancer Screening Application of TERC and P16 FISH in triage of ASCUS Oral

146 OR-0146 Oral Presentation Luyao Guan ChinaObstetrics and Gynecology Hospital of Fudan

University5. Epithelial Ovarian Cancer The role of gain-of-function mutations of RET gene in targeted therapy of epithelial ovarian cancer Poster

147 OR-0147 Oral Presentation Ziling liu China West China second hospital of sichuan university 4. Invasive Cervical Cancer Research progress in pelvic insufficiency fractures of cervical cancer after radiotherapy Poster

148 OR-0148 Oral Presentation Sigit Purbadi Indonesia Faculty of Medicine, Unoiversity of Indonesia 15. Surgical Techniques The Silent Mentor as a Media Preservice Surgical Training in Gynecologic Oncology Fellowship program. Poster

149 OR-0149 Oral Presentation Guannan Zhou ChinaDepartment of Gynecology, the Obstetrics and

Gynecology Hospital of Fudan University1. Cancer Screening Performance of a methylation analysis as a triage test for women with HPV-positive or abnormal LBC results Poster Discussion

150 OR-0150 Oral Presentation Seema Singhal India AIIMS, New Delhi 8. Rare Tumors including Uterine Sarcoma & GTD Gestational trophoblastic neoplasia: Determinants of outcome Oral

151 OR-0151 Oral Presentation LUO YAN China West China second hospital of sichuan university 3. Pre-invasive Disease and Cancer of Vulvo-Vagina A case report and literature review of primary vaginal NK/T lymphoma Poster

152 OR-0152 Oral Presentation Yu ZHAO ChinaThe Second Affiliated Hospital and Yuying Children’s

Hospital of Wenzhou Medical University1. Cancer Screening Clinicopathological Features of Multiple Primary Neoplasms Associated with Gynecological Malignancies Poster Discussion

153 OR-0153 Oral Presentation Kai Zhang China Tianjin Medical University General Hospital 7. Endometrial Hyperplasia, EIN and Endometrial CancerA novel grading system combined plasma fibrinogen and preoperative neutrophillymphocyte ratio (F-NLR) and

platelet-lymphocyte ratio (F-PLR) as prognostic predictors in endometrial cancerPoster

154 OR-0154 Oral Presentation Yibo Dai China Peking University People's Hospital 7. Endometrial Hyperplasia, EIN and Endometrial CancerDoubting the Prognostic Significance of Lymphovascular Space Invasion to Endometrioid Endometrial Cancer

Patients among Chinese Population: a Retrospective Study of 584 Cases from a Single CenterPoster

155 OR-0155 Oral Presentation Hongyi Hou China Peking University People's Hospital 15. Surgical Techniques Clinical application analysis of sentinel lymph node biopsy in cervical cancer Poster

156 OR-0156 Oral Presentation Jane Cowley USA Memorial Sloan Kettering Cancer Center 14. Clinical trials, Trials in ProgressA phase 3 trial evaluating efficacy and safety of lenvatinib in combination with pembrolizumab in patients with

advanced endometrial cancer.Poster

157 OR-0157 Oral Presentation Hongyi Hou China Peking University People's Hospital 15. Surgical Techniques Clinical application analysis of sentinel lymph node pathologic ultrastaging in early stage cervical cancer Poster

Page 8: ASGO 2019 Presentation Type for Abstracts …...ASGO 2019_Presentation Type for Abstracts Submitted by Oral Category Full Name Country Affiliation 1 OR-0001 Oral Presen ta ion Yuqin

Full Name Country Affiliation

No. Abstract No. Type

Author

Topic Title Presentation Type

158 OR-0158 Oral Presentation Fu Hung-Chun TaiwanDepartment of Obstetrics & Gynecology, Kaohsiung

Chang Gung Memorial Hospital5. Epithelial Ovarian Cancer The Roles of Androgen Receptor in Chemosensitivity in Serous Ovarian Cancer Oral

159 OR-0159 Oral Presentation Se Ik Kim South Korea

Department of Obstetrics and Gynecology, Seoul

National University College of Medicine, Seoul,

Republic of Korea

5. Epithelial Ovarian Cancer Recurrence patterns after treatment of bevacizumab in platinum-sensitive recurrent epithelial ovarian cancer Poster

160 OR-0160 Oral Presentation Se Ik Kim South KoreaDepartment of Obstetrics and Gynecology, Seoul

National University College of Medicine5. Epithelial Ovarian Cancer

Additional chemotherapy in epithelial ovarian cancer with residual disease after six cycles of postoperative

adjuvant chemotherapyOral

161 OR-0161 Oral Presentation Kittipat Charoenkwan Thailand Chiang Mai University 4. Invasive Cervical Cancer OVARIAN METASTASIS IN EARLY-STAGE CERVICAL CANCER: A LARGE SINGLE INSTITUTION STUDY Oral

162 OR-0162 Oral Presentation Tae-Kyu Jang South Korea Keimyung University Dongsan Medical Center 13. Translational Research Antitumor Effect of FGFR Inhibitor AZD4547 in Ovarian Cancer Cells Oral

163 OR-0163 Oral Presentation Soyi Lim South Korea

Department of Obstetrics & Gynecology, School of

Medicine, Gachon University, Gil Medical Center,

Incheon

7. Endometrial Hyperplasia, EIN and Endometrial Cancer The effect of combined progesterone and GnRH agonist on the growth of endometrial cancer cells Oral

164 OR-0164 Oral Presentation Yu ZHAO ChinaThe Second Affiliated Hospital and Yuying Children’s

Hospital of Wenzhou Medical University15. Surgical Techniques Application of multidirection stitching technology in laparoscopic suturing teaching Poster

165 OR-0165 Oral Presentation Xiang Zhang China University of Chinese Academy of Sciences 4. Invasive Cervical Cancer Integration of surgery and radiotherapy as treatment for patients with recurrent cervical cancer Poster

166 OR-0166 Oral Presentation Qiong ZHANG ChinaThe Second Affiliated Hospital and Yuying Children’s

Hospital of Wenzhou Medical University4. Invasive Cervical Cancer

Hidden blood loss and?its risk factors in?patients undergoing laparoscopy and?laparotomy for?cervical cancer

managementPoster

167 OR-0167 Oral Presentation Xiang Zhang China University of Chinese Academy of Sciences 4. Invasive Cervical Cancer Uterine motion limited by filled bladder in intensity-modulated radiotherapy for cervical cancer Poster

168 OR-0168 Oral Presentation Xiang Zhang China University of Chinese Academy of Sciences 10. Quality of Life Factors of acute skin toxicity for gynecologic malignancy treated with intensity-modulated radiation therapy Poster

169 OR-0169 Oral Presentation Sheng Yin China Fudan University Zhongshan Hospital 5. Epithelial Ovarian Cancer Correlation between age and short-term survival in advanced epithelial ovarian cancer Poster

170 OR-0170 Oral Presentation Perapong Inthasorn Thailand Siriraj hospital 4. Invasive Cervical CancerLAPAROSCOPIC RADICAL TRACHELECTOMY WITH ROUND LIGAMENTS AND ASCENDING BRANCHES OF

UTERINE ARTERIES PRESERVATION : OBSTETRICS AND ONCOLOGIC OUTCOME OF 8 YEARS EXPERIENCEPoster

172 OR-0172 Oral Presentation Se Ik Kim South KoreaDepartment of Obstetrics and Gynecology, Seoul

National University College of Medicine5. Epithelial Ovarian Cancer Impact of extended cycles of chemotherapy on survival outcome in recurrent epithelial ovarian cancer Poster

173 OR-0173 Oral Presentation Jee Whan Kim South KoreaWomen’s Cancer Clinic, Division of Gynecologic

Oncology7. Endometrial Hyperplasia, EIN and Endometrial Cancer

Comparison of surgical outcomes, 3-year disease free survival rate and overall survival rate between single-port

access staging laparoscopy and conventional staging laparoscopy in uterine cancerPoster

174 OR-0174 Oral Presentation Jung Hwan Ahn South Korea

Department of Obstetrics and Gynecology, Seoul St.

Mary’s Hospital, College of Medicine, The Catholic

University of Korea

4. Invasive Cervical CancerRisk factor for the postoperative lymphocele in women with cervical cancer treated with radical hysterectomy

and pelvic lymphadenectomyPoster

175 OR-0175 Oral Presentation Michał Hoppe SingaporeCancer Science Institute of Singapore, National

University of Singapore, Singapore13. Translational Research The role of hyperactive homologous recombination in survival outcomes of platinum treated ovarian carcinoma Poster Discussion

176 OR-0176 Oral Presentation Wei-Chun Chen Taiwan Chang Gung Memorial Hospital of Linkou Branch 5. Epithelial Ovarian Cancer Preliminary experience of hyperthermic intraperitoneal chemotherapy after debulking surgery for ovarian cancer Oral

177 OR-0177 Oral Presentation Min Chul Choi South KoreaComprehensive Gynecologic Cancer Center, CHA

University4. Invasive Cervical Cancer Early experiences of treatment with pembrolizumab in recurrent gynecologic malignancies Poster

178 OR-0178 Oral Presentation Yutuan Wu China

1 Department of Gynecologic Oncology, Fudan

University Shanghai Cancer Center, Fudan University,

Shanghai, China. 2 Department of Oncology, Shanghai

4. Invasive Cervical Cancer Clinical Significance of Circulating and Microenvironment Lymphocyte Subsets in Cervical Cancer Patients Poster

179 OR-0179 Oral Presentation Cheng-Chang Chang Taiwan

Department of Obstetrics and Gynecology, Tri-Service

General Hospital, National Defense Medical Center,

Taipei, Taiwan

7. Endometrial Hyperplasia, EIN and Endometrial CancerUsing deep learning with convolutional neural network approach to identify the invasion depth of myometrium

under MR images in early stage of endometrial cancer ~ a pilot study of TSGH in TaiwanOral

180 OR-0180 Oral Presentation Se Ik Kim South KoreaDepartment of Obstetrics and Gynecology, Seoul

National University College of Medicine5. Epithelial Ovarian Cancer

Effect of BRCA mutational status on survival outcome in epithelial primary peritoneal, ovarian, and fallopian

tubal cancers: experience on germline BRCA1/2 gene testing at a tertiary institutional hospital in KoreaPoster

Page 9: ASGO 2019 Presentation Type for Abstracts …...ASGO 2019_Presentation Type for Abstracts Submitted by Oral Category Full Name Country Affiliation 1 OR-0001 Oral Presen ta ion Yuqin

Full Name Country Affiliation

No. Abstract No. Type

Author

Topic Title Presentation Type

181 OR-0181 Oral Presentation Kai Zhang China Tianjin Medical University General Hospital 5. Epithelial Ovarian CancerCross-validation of genes potentially associated with neoadjuvant chemotherapy and platinum-based

chemoresistance in serous ovarian carcinomaPoster

182 OR-0182 Oral Presentation Anu Joseph India

Division of Gynaecological Oncology, Department of

Obstetrics and Gynaecology, All India Institute of

Medical Sciences, New Delhi 110029

6. Non-epithelial Ovarian cancerDOES COMPREHENSIVE SURGICAL STAGING DETERMINE THE ONCOLOGICAL OUTCOME OF MALIGNANT

OVARIAN GERM CELL TUMOUR?Poster Discussion

183 OR-0183 Oral Presentation Ajaree Senthong Thailand

Department of obstetric and Gynecological

department , Surin hospital ,Thailand.partment of

obstetric and Gynecological department , Surin

11. Supportive Care Cambodian gynecological cancer patients who received treatment at Surin province, supportive care system. Poster

184 OR-0184 Oral PresentationFitri Adinda Novianti

MahdiIndonesia Cipto Mangunkusumo Hospital 5. Epithelial Ovarian Cancer

Clinicopahology Characteristics of Ovarian Clear Cell Carcinoma Patients at Cipto Mangunkusumo Hospital on

2010 - 2015Poster

185 OR-0185 Oral Presentation Yoo-Na Kim South Korea Yonsei University College of Medicine 7. Endometrial Hyperplasia, EIN and Endometrial Cancer Comparison of outcome between one-step versus two-step sentinel lymph node biopsy in endometrial cancer Poster

186 OR-0186 Oral Presentation Yuxi Zhao China

Department of Gynecologic Oncology, National Cancer

Center/National Clinical Research Center for

Cancer/Cancer Hospital, Chinese Academy of Medical

5. Epithelial Ovarian CancerThe value of radiologic index score in multidetector computed tomography predicting tumor distribution in

advanced ovarian cancerPoster

187 OR-0187 Oral Presentation Soo Young Jeong South Korea

Departments of Obstetrics and Gynecology, Samsung

Medical Center, Sungkyunkwan University School of

Medicine

5. Epithelial Ovarian CancerImpact of intervals between secondary cytoreductive surgery and adjuvant chemotherapy in patients recurrent

epithelial ovarian cancerPoster

188 OR-0188 Oral Presentation Hyewon Chung South Korea Keimyung University School of Medicine 7. Endometrial Hyperplasia, EIN and Endometrial Cancer Consideration of next regimen for advanced endometrial cancer with microsatellite instability Poster

190 OR-0190 Oral Presentation Yoo-Young Lee South Korea Samsung Medical Center 7. Endometrial Hyperplasia, EIN and Endometrial CancerMinimally Invasive versus Abdominal Hysterectomy for Endometrial Carcinoma with Glandular or Stromal

Invasion of CervixPoster

191 OR-0191 Oral Presentation Tricia Dewi Anggraeni Indonesia

Division of Gynecology Oncology, Department of

Obstetrics and Gynecology, Faculty of Medicine,

University of Indonesia, Dr. Cipto Mangunkusumo

8. Rare Tumors including Uterine Sarcoma & GTD

Twin Pregnancy in Gestational Trophoblastic Neoplasia (GTN) with Right Cornu, Adnexal and Vaginal Metastases

Post Single Chemotherapy Regimen and External Beam Radiation Therapy (EBRT) which is Safe to Preserve

Ovarian Function

Poster

192 OR-0192 Oral Presentation Pearl Tong Singapore NUHS 5. Epithelial Ovarian Cancer Clinical characteristics of Ovarian Clear Cell Carcinoma in an Asian cohort Poster

194 OR-0194 Oral Presentation Qiaoyu Zhang China

Fujian Provincial Maternity and Children's Health

Hospital, affiliated hospital of Fujian Medical

University, Fuzhou, China

2. Pre-invasive Disease of Uterine CervixEvaluation of PCR-reverse dot blot human papillomavirus genotyping test in predicting residual/recurrent CIN 2+

in post-treatment patients in ChinaPoster

195 OR-0195 Oral Presentation Ju-Won Roh South Korea Dongguk University 13. Translational Research YAP silencing using dobutamine-PLGA nanoparticle as a new therapeutic strategy for ovarian cancer Oral

196 OR-0196 Oral Presentation Yibo Dai China Peking University People's Hospital 7. Endometrial Hyperplasia, EIN and Endometrial CancerCalcium Channel Cav1.3 Participates in Epithelial-Mesenchymal Transition of Endometrial Cancer Cells Induced

by Transforming Growth Factor βOral

197 OR-0197 Oral Presentation qiongyan wu China

Department of Women Health,Women’s Hospital,

School of Medicine, Zhejiang University, Hangzhou,

China

1. Cancer ScreeningPrimary Screening for Cervical Cancer based on High-Risk Human Papillomavirus (HPV) Detection in Zhejiang

Province, southeast ChinaPoster Discussion

198 OR-0198 Oral PresentationNugraha Utama

PelupessyIndonesia

Department of Obstetrics and Gynecology, Faculty of

Medicine, University of Hasanuddin, Makassar,

Indonesia

5. Epithelial Ovarian Cancer Cancer Stem Cell (CD133, CD44 and ALDH1A1) Markers As Prognostic Factors on Epithelial Ovarian Cancer Oral

199 OR-0199 Oral Presentation Yiqin Wang China Peking University People's Hospital 12. Fertility PreservationDoes Fertility-Sparing Treatment of Endometrial Cancer or Atypical Hyperplasia Patients Affect their Offspring on

Physical and Behavioral Development?Poster

200 OR-0200 Oral PresentationAmornrat

TemtanakitpaisanThailand

Department of Obstetrics and Gynaecology, Faculty of

Medicine, Khonkaen University, Khonkean, Thailand7. Endometrial Hyperplasia, EIN and Endometrial Cancer Outcomes of adjuvant therapy in high-risk endometrial carcinoma Poster Discussion

201 OR-0201 Oral Presentation Eun Ji Lee South Korea Seoul National University Hospital 15. Surgical Techniques Learning curve analysis and safety of splenectomy of the single gynecologic surgeon Poster

202 OR-0202 Oral Presentation Sheng Yin China Fudan University Zhongshan Hospital 5. Epithelial Ovarian CancerIncidence, risk factors and characteristics of silent pulmonary embolism in newly diagnosed ovarian cancer: a

single-institutional studyPoster

203 OR-0203 Oral Presentation Lijun Zhao China Peking University People’s Hospital 7. Endometrial Hyperplasia, EIN and Endometrial Cancer GnRH-I antagonist Cetrorelix can increase the response of endometrial cancer cells to megestrol acetate Oral

204 OR-0204 Oral Presentation Tingting Liu China Peking University People’s Hospital 7. Endometrial Hyperplasia, EIN and Endometrial CancerThe study of the effect and mechanism of arsenic trioxide combined with paclitaxel on cisplatin resistant

endometrial carcinoma cellsPoster

Page 10: ASGO 2019 Presentation Type for Abstracts …...ASGO 2019_Presentation Type for Abstracts Submitted by Oral Category Full Name Country Affiliation 1 OR-0001 Oral Presen ta ion Yuqin

Full Name Country Affiliation

No. Abstract No. Type

Author

Topic Title Presentation Type

205 OR-0205 Oral Presentation Yiqin Wang China Peking University People's Hospital 12. Fertility PreservationFrom circulating to pathological biomarkers: a dynamic study of fertility-sparing treatment of endometrial cancer

and atypical hyperplasiaPoster

206 OR-0206 Oral Presentation Aliya Begum Pakistan Aga Khan University Hospital 1. Cancer Screening CHALLENGES OF MANAGEMENT OF GYNECOLOGICAL CANCER IN LMIC Poster

207 OR-0207 Oral Presentation Yujia Kong China Peking Union Medical College Hospital 8. Rare Tumors including Uterine Sarcoma & GTD Management and prognosis of relapsed gestational trophoblastic neoplasia: a 14-year experience Poster

208 OR-0208 Oral Presentation SANGIL KIM South Korea

Department of Obstetrics and Gynecology, College of

Medicine, St. Vincent’s hospital, The Catholic University

of Korea

4. Invasive Cervical CancerComparative Outcomes between abdominal and tumor-sealing Laparoscopic Radical Hysterectomy in cervical

cancer : Results from a single surgeon's experiencePoster

209 OR-0209 Oral PresentationMUHAMMAD ASYRAF

AZIZANMalaysia UNIVERSITY MALAYA MEDICAL CENTER 5. Epithelial Ovarian Cancer

Inadvertent ovarian malignancy following operative laparoscopy of adnexal masses: University Malaya Medical

Centre experience.Oral

210 OR-0210 Oral Presentation Vijaya shanti India RCC 5. Epithelial Ovarian CancerCIRCULATING CELL FREE DNA LEVELS IN ADVANCED EPITHELIAL OVARIAN CANCER: CAN WE PREDICT

OPTIMAL CYTOREDUCTION?Poster

211 OR-0211 Oral Presentation Anuradha Suberamaniam Malaysia University of Malaya Medical Centre, Kuala Lumpur 14. Clinical trials, Trials in ProgressMainstreaming Genetic Counselling for Genetic Testing of BRCA1 and BRCA2 in Ovarian Cancer Patients in

Malaysia (MaGiC Study)Poster

212 OR-0212 Oral Presentation Hwajung Lee South Korea Yonsei University College of Medicine 4. Invasive Cervical CancerImpact of learning curve on the survival of abdominal or minimally invasive radical hysterectomy for early stage

cervical cancerOral

213 OR-0213 Oral Presentation Heng-Cheng Hsu TaiwanObstetrics and Gynecology, National Taiwan University

Hospital Hsin-Chu Branch, Hsin-Chu City, Taiwan13. Translational Research Blockade of PD-L1 Enhances Cancer ImmunotherapybyRegulating Dendritic Cell Maturation Poster

214 OR-0214 Oral Presentation Naratassapol Likitdee Thailand

Department of Obstetrics and gynaecology, Faculty of

Medicine, Khon Kaen University, Khon Kaen 40002,

Thailand

1. Cancer Screening Quality assessment of websites providing information on HPV vaccines in Thailand Oral

215 OR-0215 Oral Presentation laila nuranna Indonesia FMUI 1. Cancer ScreeningDocumentation of Visual Inspection with Acetic Acid (DoVIA) as alternative screening cervical cancer program in

IndonesiaPoster Discussion

216 OR-0216 Oral Presentation Rashmi Bagga India

Professor, Obstetrics & Gynaecology, Post Graduate

Institute of Medical Education & Research, Chandigarh,

India

3. Pre-invasive Disease and Cancer of Vulvo-VaginaMANAGEMENT OF FOUR WOMEN WITH VULVAR CANCER OF UNUSUAL HISTOLOGY: PAGET'S DISEASE,

RHABDOMYOSARCOMA, ADENOID CYSTIC CARCINOMA AND MELANOMAPoster

217 OR-0217 Oral Presentation Jinhui Wang ChinaDepartment of Obstetrics and Gynecology, Peking

Union Medial College Hospital6. Non-epithelial Ovarian cancer Salvage therapy for patients with recurrent and persistent malignant ovarian germ cell tumors Poster Discussion

218 OR-0218 Oral Presentation Sichen Liang China Peking University People's Hospital 7. Endometrial Hyperplasia, EIN and Endometrial CancerCarbon nanoparticles compared with indocyanine green in sentinel lymph node detection in endometrial

carcinoma, which is better? A retrospective single-center study in 153 cases in China.Poster Discussion

219 OR-0219 Oral Presentation zhengmao zhang China Fourth Hospital of Hebei Medical University 5. Epithelial Ovarian Cancer Analysis of factors influencing the recurrence and fertility outcomes of ovarian borderline tumors Oral

220 OR-0220 Oral Presentation Jie Zhu ChinaDepartment of Gynecology, Obstetrics and Gynecology

Hospital of Fudan University5. Epithelial Ovarian Cancer The role and mechanism of KPC1 ubiquitin ligase in epithelial ovarian cancer Poster Discussion

221 OR-0221 Oral Presentation David Tan Singapore

National University Cancer Institute, Singapore;;

National University Hospital and Cancer Science

Institute, National University of Singapore,

5. Epithelial Ovarian CancerFirst-in-human trial of the oral ataxia telangiectasia and Rad3-related (ATR) inhibitor BAY 1895344 in patients

(pts) with advanced solid tumors.Oral

222 OR-0222 Oral Presentation Dan Wang ChinaDepartment of Obstetrics and Gynecology, Peking

Union Medical College Hospital8. Rare Tumors including Uterine Sarcoma & GTD

Diagnosis and management of growing teratoma syndrome after ovarian immature teratoma: a single center

experiencePoster

223 OR-0223 Oral Presentation VANDANA JAIN IndiaRajiv Gandhi Cancer Institute and research centre,

Delhi8. Rare Tumors including Uterine Sarcoma & GTD EVALUATION OF FACTORS PREDICTING RECURRENCE IN BORDERLINE OVARIAN TUMORS Poster

224 OR-0224 Oral Presentation SU HYUN CHAE South Korea Konkuk Medical Center 7. Endometrial Hyperplasia, EIN and Endometrial CancerThe oncologic outcome after long term fertility-sparing hormonal management for early stage endometrioid

endometrial cancerOral

225 OR-0225 Oral Presentation Zhyra Gail Catli Philippines Jose B. Lingad Memorial Regional Hospital - Resident 8. Rare Tumors including Uterine Sarcoma & GTD The Challenge in Diagnosing Endometrial Stromal Sarcoma Poster

226 OR-0226 Oral Presentation Zhiying Lu ChinaDepartment of Gynecology, The Obstetrics and

Gynecology Hospital of Fudan University, Shanghai4. Invasive Cervical Cancer A retrospective analysis of surgery for cervical stump carcinoma at early stage(IA2-IIA2) Poster

Page 11: ASGO 2019 Presentation Type for Abstracts …...ASGO 2019_Presentation Type for Abstracts Submitted by Oral Category Full Name Country Affiliation 1 OR-0001 Oral Presen ta ion Yuqin

Full Name Country Affiliation

No. Abstract No. Type

Author

Topic Title Presentation Type

227 OR-0227 Oral Presentation Emiko Yoshida JapanJuntendo University, Department of Obstetrics and

Gynecology7. Endometrial Hyperplasia, EIN and Endometrial Cancer

Development of novel diagnosis method of uterine cancer using lymph node metastasis predictive biomarker for

more personalized lymphadenectomy.Oral

228 OR-0228 Oral Presentation Hirofumi Inaba Japan The University of Tokyo 8. Rare Tumors including Uterine Sarcoma & GTD Clinical sequencing by Todai OncoPanel (TOP) for uterine sarcomas Poster Discussion

229 OR-0229 Oral Presentation Hung-Cheng Lai Taiwan Taipei Medical University/Shuang Ho Hospital 7. Endometrial Hyperplasia, EIN and Endometrial CancerDiagnostic accuracy of MPap™ in women with abnormal uterine bleeding for endometrial cancer: preliminary

report of a multicenter validating confirmatory studyOral

230 OR-0230 Oral Presentation Joo-Hyuk Son South Korea

Division of Gynecologic Oncology, Department of

Obstetrics and Gynecology, Ajou University School of

Medicine, Suwon, Republic of Korea

4. Invasive Cervical CancerSelection criteria and colpotomic approach for safe minimally invasive radical hysterectomy in early-stage

cervical cancerPoster

231 OR-0231 Oral Presentation Chihiro Ishizawa JapanDepartment of Obstetrics and Gynecology, Faculty of

Medicine, The University of Tokyo4. Invasive Cervical Cancer Post-surgical prognosis of low and medium-risked cervical cancer and its correlation with adjuvant treatment Poster

232 OR-0232 Oral Presentation Dwi Faradina Indonesia University of Sumatera Utara 5. Epithelial Ovarian Cancer Management of Advanced Stage Epithelial Ovarian Cancer in Older Patients in Adam Malik Hospital Poster

233 OR-0233 Oral Presentation Qiyu Liu ChinaObstetrics and Gynecology Hospital, Fudan University,

Shanghai, China5. Epithelial Ovarian Cancer

Gonadotropin-releasing hormone receptor-targeted near-infrared fluorescence probe for specific recognition and

localization of peritoneal metastases of ovarian cancerPoster Discussion

234 OR-0234 Oral Presentation Ting-Chang Chang Taiwan Chang Gung Memorial Hospital at Linkou 14. Clinical trials, Trials in ProgressCan Neoadjuvant PD-1 Blockade Reduce Risk of Distant Relapse after Primary Therapy for Resectable, Advanced

Gynecologic Malignancies?Poster

235 OR-0235 Oral Presentation Sikarn Satitniramai Thailand Ramathibodi hospital, Mahidol university 5. Epithelial Ovarian CancerDoes Inclusion of Pegylated Liposomal Doxorubicin in the Management of Progressive or Recurrent Ovarian

Cancer Improve Overall Survival ?Poster

236 OR-0236 Oral Presentation Chompunoot Kongsawatvorakul Thailand ramathibodi hospital 5. Epithelial Ovarian Cancer Effectiveness of oral etoposide in recurrent or refractory epithelial ovarian cancer and primary peritoneal cancer Poster

237 OR-0237 Oral Presentation SungJong Lee South KoreaBucheon St. Mary's Hospital, The Catholic University of

Korea13. Translational Research

Efficient tumor clearance by stimulated CD8+ T cell through combination immunotherapies in cervical cancer

bearing mouse.Poster

238 OR-0238 Oral Presentation Xiaoting Ling China Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University 12. Fertility Preservation Modified laparoscopic radical trachelectomy for early stage cervical cancer Poster Discussion

239 OR-0239 Oral Presentation Romelyn Imperio-Onglao Philippines Philippine General Hospital 8. Rare Tumors including Uterine Sarcoma & GTD RECURRENT PAGET’S DISEASE OF THE VULVA IN A SPLIT-THICKNESS GRAFT Poster

240 OR-0240 Oral Presentation Romelyn Imperio-Onglao Philippines Philippine General Hospital 3. Pre-invasive Disease and Cancer of Vulvo-Vagina A Rare Case of Invasive Vaginal Carcinoma post Vaginal Hysterectomy Poster

241 OR-0241 Oral Presentation Ming-Yin Lin Austrailia Peter MacCallum Cancer Centre 7. Endometrial Hyperplasia, EIN and Endometrial Cancer Selecting endometrial cancer patients for high risk of recurrence Oral

Page 12: ASGO 2019 Presentation Type for Abstracts …...ASGO 2019_Presentation Type for Abstracts Submitted by Oral Category Full Name Country Affiliation 1 OR-0001 Oral Presen ta ion Yuqin

Full Name Country Affiliation

1 PO-0001 Poster Haewon Kim South Korea Seoul National University 12. Fertility Preservation Korean nurses' attitude toward cancer treatment during pregnancy Poster

2 PO-0002 Poster Haewon Kim South Korea Seoul National University 11. Supportive Care Men’s Awareness of Cervical Cancer Poster

3 PO-0003 Poster Jimmy Billod Philippines Baguio General Hospital and Medical Center 10. Quality of LifeTiming of urinary catheter removal after radical hysterectomy for cervical and endometrial cancer . A single

institution study.Poster

5 PO-0004 Poster Rachadapan Chaitosa Thailand Ramathibodi hospital 10. Quality of LifeA longitudinal study of symptom experience in Ramathibodi Hospital cervical cancer patients receive

chemotherapy: CisplatinPoster

9 PO-0005 Poster Aubrey Seneris Philippines Philippine General Hospital 3. Pre-invasive Disease and Cancer of Vulvo-Vagina BASAL CELL CARCINOMA OF THE VULVA: A CASE REPORT Poster

10 PO-0006 Poster Yuyeon Jung South Korea Seoul St. Mary's hospital 13. Translational ResearchCKD-602, a topoisomerase I inhibitor, induces apoptosis and cell-cycle arrest and inhibits invasion in murine

cervical cancerPoster

17 PO-0007 Poster Htun Lynn Soe Myanmar N/A 1. Cancer ScreeningImpact of Visual Inspection of the cervix after application with Acetic Acid (VIA) followed by Cryotherapy

treatment (See and Treat Approach) for Secondary Cervical Cancer Prevention in Pathein Township, MyanmarPoster

22 PO-0008 Poster Asami Ikeda JapanDepartment of Obstetrics and Gynecology, National

Hospital Organization Kyoto Medical Center5. Epithelial Ovarian Cancer Serum lactate dehydrogenase is a possible predictor of platinum resistance in ovarian cancer Poster

23 PO-0009 Poster Kanako Kono Japan2. Division of Screening Assessment and Management,

National Cancer Center, Tokyo, Japan1. Cancer Screening Cervical cancer screening trends and geographical distribution in Japan Poster

26 PO-0010 Poster SHIMOMURA MASAHIRO Japan Osaka City University Graduate School of Medicine 4. Invasive Cervical CancerPaclitaxel plus cisplatin as adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk

stage IB-IIB cervical cancer.Poster

27 PO-0011 Poster FUMIHIRO MURAKAMI Japan St. Mary’s Hospital 5. Epithelial Ovarian Cancer A case of ovarian serous borderline tumor in a 12-years-old girl. Poster

28 PO-0012 Poster Dhammapoj Jeerakornpassawat Thailand Chiang Mai University 5. Epithelial Ovarian CancerPredictive Factors for Chemotherapeutic Response and Prognosis in Epithelial Ovarian, Fallopian Tube and

Primary Peritoneal Cancer Patients Treated with Platinum-Based ChemotherapyPoster

29 PO-0013 Poster Hiroaki Matsubara Japan Osaka City University Graduate School of Medicine 5. Epithelial Ovarian CancerEvaluation of efficacy and safety of bevacizumab for advance and recurrent Mullerian carcinoma in our

institution.Poster

30 PO-0014 Poster Anyue Wu ChinaRen Ji Hospital, School of Medicine, Shanghai JiaoTong

University7. Endometrial Hyperplasia, EIN and Endometrial Cancer

Suppressive effect of microRNA-449a on the NDRG1/PTEN/AKT axis regulates endometrial cancer growth and

metastasisPoster

35 PO-0015 Poster Yao-Ching Hung Taiwan China Medical Univ. Hosp. 13. Translational ResearchIncrease Paclitaxel Sensitivity to Better Suppress Serous Epithelial Ovarian Cancer via Ablating Androgen

Receptor/Aryl Hydrocarbon Receptor-ABCG2 AxisPoster

37 PO-0016 Poster Can He China Zhongnan hospital affiliated Wuhan University 5. Epithelial Ovarian Cancer Log( CA125 )/PCI can predict residual tumors in epithelial ovarian cancer:A retrospective study Poster

38 PO-0017 Poster Can He China Zhongnan hospital affiliated Wuhan University 1. Cancer ScreeningCommunity-based Educational Intervention for Cervical Cancer Prevention (CEDIC trial) in Nepal? A Cluster

Randomized Controlled TrialPoster

40 PO-0018 Poster Geminelle Co Philippines Philippine General Hospital 7. Endometrial Hyperplasia, EIN and Endometrial Cancer Tumor Size as Independent Prognostic Factor in Stage IA Endometrioid Endometrial Adenocarcinoma Poster

43 PO-0019 Poster Can He China Zhongnan Hospital of Wuhan University 10. Quality of Life Quality of life of patient with ovarian cancer in Hubei, China Poster

45 PO-0020 Poster BRIAN PRIMA ARTHA Indonesia FKUI/RSCM 7. Endometrial Hyperplasia, EIN and Endometrial CancerEvaluation of Myometrial Invasion in Type I Endometrial Cancer Using Magnetic Resonance Diffusion Weighted

ImagingPoster

ASGO 2019_Presentation Type for Abstracts Submitted by Poster Category

Presentation TypeNo. Abstract No. Type

Author

Topic Title

Page 13: ASGO 2019 Presentation Type for Abstracts …...ASGO 2019_Presentation Type for Abstracts Submitted by Oral Category Full Name Country Affiliation 1 OR-0001 Oral Presen ta ion Yuqin

Full Name Country Affiliation

Presentation TypeNo. Abstract No. Type

Author

Topic Title

50 PO-0021 Poster Soo Young Jeong South Korea Samsung Medical Center 13. Translational Research Anti-cancer effect of PARP inhibitor (olaparib) with DNA-demethylating agents(5-azacytidine) in ovarian cancer Poster

52 PO-0022 Poster Rachadapan Chaitosa Thailand Ramathibodi hospital 10. Quality of Life Side effects among patients with invasive cervical cancer receiving Cisplatin by age range: Prospective study. Poster

58 PO-0023 Poster Yasaka Miwa Japan Tokai University School of Medicine 4. Invasive Cervical Cancer Profile of trachelectomy in women with early-stage cervical cancer: A nationwide cohort study in Japan Poster

59 PO-0024 Poster herdhana suwartono Indonesia INASGO 1. Cancer Screening Efficacy of Trichloroacetic Acid (TCA) Compared to Cryotherapy in Treating Patients with Positive IVA Result Poster

67 PO-0025 Poster Mi Gong ChinaThe First Affiliated Hospital of Nanjing Medical

University1. Cancer Screening Decoding the regulatory role of LINC00565 in accelerating ovarian cancer progression Poster

68 PO-0026 Poster Mi Gong ChinaThe First Affiliated Hospital of Nanjing Medical

University5. Epithelial Ovarian Cancer CTCFL is an up-regulated gene in high-grade epithelial ovarian cancer by genome-wide bioinformatics analysis Poster

71 PO-0027 Poster Xiaoliang Liu China

Peking Union Medical College Hospital, Chinese

Academy of Medical Sciences & Peking Union Medical

College

4. Invasive Cervical Cancer Predictors of Distant Metastasis in Patients with Cervical Cancer Treated with Definitive Radiotherapy Poster

72 PO-0028 Poster Yu Xia China Shengjing hospital of China medical university 9. Genetics Investigation on the sensitive biomarkers of the genome Poster

73 PO-0029 Poster Yang Xiang ChinaPeking Union Medical College Hospital, Chinese

Academy of Medical Sciences8. Rare Tumors including Uterine Sarcoma & GTD PD-L1, B7-H3 and VISTA are highly expressed in gestational trophoblastic neoplasia Poster

80 PO-0030 Poster HONG BAE KIM South Korea Kangnam sacred heart hospital 8. Rare Tumors including Uterine Sarcoma & GTD Lymphocyte-monocyte ratio predicts uterine sarcoma aggressiveness Poster

83 PO-0031 Poster Yuta Inoue Japan Osaka City University Graduate School of Medicine 4. Invasive Cervical CancerProtective effect of magnesium supplementation on cisplatin- induced renal toxicity in patients with uterine

cervical cancerPoster

89 PO-0032 Poster Kyung-Jin Min South Korea Korea University Medicine 10. Quality of Life Short-term benefits of balneotherapy for patients with chronic pelvic pain: a pilot study in Korea Poster

96 PO-0033 Poster Xiuqin Li ChinaShengjing Hospital Affiliated to China Medical

University5. Epithelial Ovarian Cancer Development and Application of a Platinum Hypersensitivity Risk Scoring System Poster

97 PO-0034 Poster Jehada-Inn Misuari-Alihuddin Philippines Philippine General Hospital 5. Epithelial Ovarian CancerClinical Characteristics Predictive of Optimal Primary Cytoreduction in Epithelial Ovarian Malignancy: A Five-year

Retrospective Study in a Tertiary Government HospitalPoster

99 PO-0035 Poster Cheryl Chun JapanSaitama Medical University International Medical

Center, Hidaka, Saitama, Japan14. Clinical trials, Trials in Progress

ATHENA (GOG-3020/ENGOT-ov45): A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of the

Poly(ADP-Ribose) Polymerase (PARP) Inhibitor Rucaparib + the PD-1 Inhibitor Nivolumab Following Frontline

Platinum-Based Chemotherapy in Ovarian Cancer

Poster

102 PO-0036 Poster Hidenori Sasa Japan National Defense Medical College 2. Pre-invasive Disease of Uterine Cervix Expectant management of pregnant and postpartum women with cervical intraepithelial neoplasia Poster

107 PO-0037 Poster Ni Ni Thein Myanmar Central Women's Hospital, Yangon 4. Invasive Cervical Cancer Effectiveness of Neoajuvant Chemotherapy in Cervical Carcinoma (FIGO Stage IB2, IIA2 and IIB) Poster

110 PO-0038 Poster Seob Jeon South Korea Soonchunhyang university Cheonan hospital 4. Invasive Cervical Cancer Advanced gastric type endocervical adenocarcinoma not reponsive to paclitaxel, cisplatin, and bevacizumab Poster

115 PO-0039 Poster Dongling Zou China Chongqing university cancer hospital 1. Cancer ScreeningDistribution of human papillomavirus genotypes in 533 women with cervical lesions in Chongqing, Southwest

ChinaPoster

118 PO-0040 Poster Michele McColgan South Korea Seoul National University Hospital, Seoul 14. Clinical trials, Trials in ProgressKEYNOTE-826: a phase 3 randomized trial of chemotherapy with and without pembrolizumab for first-line

treatment of advanced cervical cancerPoster

120 PO-0041 Poster Seongmin Kim South Korea KU Medicine 15. Surgical TechniquesSentinel lymph node mapping using indocyanine green in robotic surgery for the treatment of endometrial

cancer and early-staged cervical cancerPoster

121 PO-0042 Poster Miseon Kim South Korea

Department of Obstetrics and Gynecology, CHA

Gangnam Medical Center, CHA University School of

Medicine, Seoul, Korea

2. Pre-invasive Disease of Uterine Cervix Cervical intraepithelial neoplasia-2 of women in their twenties: which is the best management? Poster

Page 14: ASGO 2019 Presentation Type for Abstracts …...ASGO 2019_Presentation Type for Abstracts Submitted by Oral Category Full Name Country Affiliation 1 OR-0001 Oral Presen ta ion Yuqin

Full Name Country Affiliation

Presentation TypeNo. Abstract No. Type

Author

Topic Title

122 PO-0043 Poster KEN MATSUKUMA Japan Kurume university 5. Epithelial Ovarian CancerChemotherapy response score is a prognostic factor in patients with ovarian cancer who underwent neoadjuvant

chemotherapy and interval debulking surgery.Poster

123 PO-0044 Poster Kouichiro Kawano Japan Kurume University 2. Pre-invasive Disease of Uterine CervixUsefulness of human papillomavirus genotyping to predict residual/recurrent disease after conservative

treatment of cervical intraepithelial neoplasia compared with HPV DNA testing.Poster

124 PO-0045 Poster Bernadette Yap Philippines UP-Philippine General Hospital 7. Endometrial Hyperplasia, EIN and Endometrial CancerVaginal recurrence in Sentinel Lymph Node Biopsy-Negative Stage IA Endometrial Carcinoma using Near-

Infrared Fluorescence with Indocyanine Green DyePoster

125 PO-0046 Poster Limavel Ann Veloso Philippines Society of Gynecologic Oncologists of the Philippines 1. Cancer ScreeningClinical characteristics and prognosis of cervical cancer among Filipino women ages 35 years old and below: A

retrospective cohort studyPoster

126 PO-0047 Poster Chia-Ying Wu TaiwanDepartment of Obstetrics and Gynecology, National

Taiwan University Hospital7. Endometrial Hyperplasia, EIN and Endometrial Cancer

Correlation of Preoperative Assessment by Magnetic Resonance Imaging and Clinicopathologic Results in

Endometrial CancerPoster

130 PO-0048 Poster Yuxi Zhao ChinaCancer Hospital Chinese Academy of Medical Science

and Peking Union Medical College5. Epithelial Ovarian Cancer

Prevalence and predictors of hematological toxicity on adjuvant chemotherapy and the prognosis in geriatric

patients with epithelial ovarian cancer: A two-center retrospective cohort study.Poster

132 PO-0049 Poster Haili Kang China Gynecologic Oncology 4. Invasive Cervical Cancer Surgical treatment of young locally advanced cervical squamous cell carcinoma Poster

133 PO-0050 Poster Sungpil Choo South KoreaDepartment of Obstetrics and Gynecology, Yonsei

University College of Medicine, Seoul, Korea9. Genetics Correlation between Homeobox gene upregulation and poor survival outcomes in cervical carcinoma Poster

134 PO-0051 Poster Sungpil Choo South Korea Department of Obstetrics and Gynecology, 9. GeneticsDysregulated expression of Homeobox family genes may influence survival outcomes of patients with epithelial

ovarian cancer: Analysis of data from The Cancer Genome AtlasPoster

136 PO-0052 Poster Yukiharu Todo Japan Hokkaido Cancer Center 7. Endometrial Hyperplasia, EIN and Endometrial CancerImaging-based definition of lower uterine segment carcinoma to improve the detection sensitivity of probable

Lynch syndromePoster

137 PO-0053 Poster Keiichi Fujiwara JapanSaitama Medical University International Medical

Center14. Clinical trials, Trials in Progress

Randomized Phase III Trial of Long-term Low-dose Metronomic UFT Maintenance Therapy versus Observation

after Chemoradiation Therapy for Locally Advanced Cervical Cancer (GOTIC-002)Poster

138 PO-0054 Poster Shoji Nagao Japan Hyogo Cancer Center 14. Clinical trials, Trials in Progress

A randomized phase II/III trial of 3 weekly intraperitoneal versus intravenous carboplatin in combination with

intravenous weekly dose-dense paclitaxel for newly diagnosed ovarian, fallopian tube and primary peritoneal

cancer. A GOTIC-001/JGOG3019/GCIG Study (iPocc Trial)

Poster

139 PO-0055 Poster Kathleen Gizelle Alfonso Philippines Society of Gynecologic Oncologists of the Philippines 7. Endometrial Hyperplasia, EIN and Endometrial Cancer Risk Factors For Tumor Recurrence In Surgically Managed Endometrial Cancer: A Cohort Study Poster

141 PO-0056 Poster Andrew Wijaya Indonesia Universitas Indonesia 5. Epithelial Ovarian CancerThe Myelosuppresive Effect and Nephrotoxicity of Chemotherapies in Ovarian Cancer Patients: A Single-Center

StudyPoster

144 PO-0057 Poster Won Kyung Cho South KoreaDepartment of Radiation Oncology, Samsung Medical

Center, Sungkyunkwan University School of Medicine4. Invasive Cervical Cancer Significance of tumor size in IB-IIA cervical cancer with pathologic risk factors following hysterectomy Poster

147 PO-0058 Poster Tendi Robby Setia IndonesiaDepartment Obstetrics and Ginecology Hasan Sadikin

Hospital2. Pre-invasive Disease of Uterine Cervix The role Bacille Calmette-Guerin BCG TO Low grade cervical precancerous lesions. Poster

149 PO-0059 Poster Kim InHye South KoreaDepartment of Obstetrics and Gynecology, Pusan

National University School of Medicine, Busan, Korea5. Epithelial Ovarian Cancer Stromal tumor-infiltrating lymphocytes as an independent prognostic factor in epithelial ovarian cancer Poster

150 PO-0060 Poster Kim InHye South KoreaDepartment of Obstetrics and Gynecology, Pusan

National University School of Medicine, Busan, Korea5. Epithelial Ovarian Cancer Prognostic significance of CD109 expression in patients with epithelial ovarian cancer Poster

151 PO-0061 Poster Kim InHye South KoreaDepartment of Obstetrics and Gynecology, Pusan

National University School of Medicine, Busan, Korea5. Epithelial Ovarian Cancer

PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable independent prognostic factor in

epithelial ovarian carcinomaPoster

154 PO-0062 Poster Futoshi Arakane Japan Japanse Red Cross Kumaoto Hospital 8. Rare Tumors including Uterine Sarcoma & GTD Clear cell carcinoma arising from cystic adenomyosis treated with laparoscopic surgery;; a case report Poster

155 PO-0063 Poster Myeong Seon Kim South Korea

Department of Obstetrics and Gynecology, Samsung

Medical Center, Sungkyunkwan University School of

Medicine

4. Invasive Cervical Cancer Pulmonary lymphangitic metastasis in cervical cancer : case series Poster

158 PO-0064 Poster Nutthaporn Chandeying Thailand Navamindradhiraj University 10. Quality of Life Sexual Function in Cervical Cancer Survivors: A Multi-level Meta-analysis with Qualitative Comparative Analysis Poster

Page 15: ASGO 2019 Presentation Type for Abstracts …...ASGO 2019_Presentation Type for Abstracts Submitted by Oral Category Full Name Country Affiliation 1 OR-0001 Oral Presen ta ion Yuqin

Full Name Country Affiliation

Presentation TypeNo. Abstract No. Type

Author

Topic Title

159 PO-0065 Poster RURI OTAKI Japan Osaka Medical College Hospital 4. Invasive Cervical Cancer The texture analysis of FDG PET/CT in cervical cancer Poster

160 PO-0066 Poster Renee Riza Medalla Philippines Philippine General Hospital 8. Rare Tumors including Uterine Sarcoma & GTD The Accuracy of Ultrasound in Diagnosing First Trimester Molar Pregnancy Poster

163 PO-0067 Poster Yoo-Young Lee South Korea Samsung Medical Center 13. Translational ResearchRole of inhibition of Fibroblast Growth Factors (FGFs) / Fibroblast Growth Factor Receptors (FGFRs) axis in

epithelial ovarian cancerPoster

164 PO-0068 Poster Ching Yu Cheng TaiwanNational Taiwan Universtiy Hospital , Department of

Obstetrics and Gynecology5. Epithelial Ovarian Cancer Outcome of women unexpectedly diagnosed ovary cancer Poster

166 PO-0069 Poster E Sun Paik South Korea

Department of Obstetrics and Gynecology, Samsung

Medical Center, Sungkyunkwan University School of

Medicine, Seoul, Korea

4. Invasive Cervical Cancer BRCA1 immunohistochemistry expression and survival in cervical cancer Poster

167 PO-0070 Poster E Sun Paik South Korea

Department of Obstetrics and Gynecology, Samsung

Medical Center, Sungkyunkwan University School of

Medicine, Seoul, Korea

7. Endometrial Hyperplasia, EIN and Endometrial CancerComparison of laparoscopy and laparotomy for paraaortic lymphadenectomy in women with high-risk

endometrial cancerPoster

169 PO-0071 Poster E Sun Paik South Korea

Department of Obstetrics and Gynecology, Samsung

Medical Center, Sungkyunkwan University School of

Medicine, Seoul, Republic of Korea

5. Epithelial Ovarian CancerReal-world experience of olaparib maintenance in high grade serous recurrent ovarian cancer patients with BRCA

1/2 mutation : Korean multicenter studyPoster

170 PO-0072 Poster Yin Min China The Affiliated Hospital of Qingdao University 5. Epithelial Ovarian Cancer Impact of Human Cytomegalovirus Infection on Survival of Patients with Ovarian Cancer Poster

174 PO-0073 Poster ajaree senthong Thailand Surin hospital 8. Rare Tumors including Uterine Sarcoma & GTDEmbryonal rhabdomyosarcoma arising from uterine corpus in a postmenopausal woman : A Case Report and

literature reviewPoster

178 PO-0074 Poster Sze Ki Hui Hong Kong Hospital Authority 5. Epithelial Ovarian Cancer Mimicker of Advanced Ovarian Cancer ? Peritoneal Tuberculosis Poster

179 PO-0075 Poster YONG IL JI South Korea INJE university 2. Pre-invasive Disease of Uterine CervixComparision of histological outcomes from pre-menopausal and post-menopausal women with report of cervical

cytological abnormalityPoster

185 PO-0076 Poster Jung Mi Byun South Korea

Department of Obstetrics and Gynecology, Busan Paik

Hospital, Inje University, College of Medicine, South

Korea

4. Invasive Cervical Cancer Clinical significance of the pattern-based classification in endocervical adenocarcinoma, usual and variants Poster

187 PO-0077 Poster Nintita Thokanit ThailandRamathibodi Cancer Center, Ramathibodi Hospital,

Mahidol University4. Invasive Cervical Cancer Prognostic factors of cervical cancer in University hospital including HIV status Poster

194 PO-0078 Poster Shogo Shigeta JapanDepartment of Obstetrics and Gynecology, Tohoku

University Hospital4. Invasive Cervical Cancer

A clinicopathological analysis of 2,378 patients with FIGO 2018 stage IB1/IB2 cervical cancer by Japanese

Gynecologic Oncology Group Network (JGOG 1072s)Poster

196 PO-0079 Poster Seongmin Kim South Korea KU Medicine 4. Invasive Cervical Cancer Learning curve could affect the surgical outcome of radical hysterectomy in cervical cancer Poster

205 PO-0080 Poster Lingxiao Luo ChinaObstetrics and Gynecology Hospital of Fudan

University8. Rare Tumors including Uterine Sarcoma & GTD The Preliminary Exploration of Circulating Free DNA in Gestational Trophoblastic Neoplasia Poster

206 PO-0081 PosterNattapong

SermsukcharoenchaiThailand Phramongkutklao hospital 1. Cancer Screening

A correlation of reporting cervical cytology between gravity sedimentation liquid-based cytology and

conventional Papanicolaou smearsPoster

207 PO-0082 Poster Alexander Shushkevich Belarus N.N.Alexandrov Cancer Center of Belarus 7. Endometrial Hyperplasia, EIN and Endometrial Cancer Comparative assessment of survival rate in endometrial cancer intermediate risk Poster

211 PO-0083 PosterMohd Norazam Mohd

AbasMalaysia National Cancer Institute 5. Epithelial Ovarian Cancer

IMPACT OF PRE-OPERATIVE WHEY PROTEIN INFUSED CARBOHYDRATE LOADING AND POST-OPERATIVE EARLY

ORAL FEEDING IN OVARIAN CANCER PATIENTS UNDER FAST TRACT SURGERY SETTINGPoster

214 PO-0084 Poster Ju-Hyun Kim South Korea Asan Medical Center 12. Fertility PreservationOncological outcomes and recurrent risk factors following laparoscopic radical trachelectomy with vaginal

colpotomy in early-stage cervical cancerPoster

215 PO-0085 Poster Ju-Hyun Kim South Korea Asan Medical Center 8. Rare Tumors including Uterine Sarcoma & GTDPrognostic factors and impact of the minimally invasive surgery in early-stage neuroendocrine carcinoma of

cervixPoster

216 PO-0086 Poster Suci Amaliah IndonesiaObstetric and Gynecology Department, Faculty of

Medicine, Hasanuddin University, Makassar, Indonesia4. Invasive Cervical Cancer

Factors That Influence 1 Year Survival Rate in Cervical Cancer Patient at Wahidin Sudirohusodo Hospital,

Makassar, IndonesiaPoster

Page 16: ASGO 2019 Presentation Type for Abstracts …...ASGO 2019_Presentation Type for Abstracts Submitted by Oral Category Full Name Country Affiliation 1 OR-0001 Oral Presen ta ion Yuqin

Full Name Country Affiliation

Presentation TypeNo. Abstract No. Type

Author

Topic Title

217 PO-0087 Poster Putsarat Insin ThailandDepartment of Obstetrics and Gynecology, Rajavithi

Hospital, Bangkok, Thailand.7. Endometrial Hyperplasia, EIN and Endometrial Cancer Association of Preoperative Serum HE4 Levels on Survival of Patients with Endometrial Cancer Poster

219 PO-0088 Poster Tsutomu Ida JapanDepartment of Obstetrics and Gynecology, Tokyo

Metropolitan Tama Medical Center7. Endometrial Hyperplasia, EIN and Endometrial Cancer

Successful removal of a peritoneovenous shunt for severe chylous ascites after a para-aortic lymphadenectomy:

a case reportPoster

224 PO-0089 Poster Chia-Shu Lu Taiwan National Taiwan University Hospital Hsin-Chu Branch 5. Epithelial Ovarian Cancer The Safety and Efficacy of Weekly Versus Conventional 5-day Topotecan in Recurrent Epithelial Ovarian Cancers Poster

225 PO-0090 Poster Gao Xiu China West China Second Hospital of Sichuan University 8. Rare Tumors including Uterine Sarcoma & GTDEvaluation of clinical efficacy and safety of initial chemotherapy for 347 cases of gestational trophoblastic

neoplasiaPoster

227 PO-0091 Poster Nintita Thokanit Thailand Ramathibodi Hospital, Mahidol University 4. Invasive Cervical Cancer Comparison of cervical survival: Stage at diagnosis and HIV/AIDS infected cervical cancer patient. Poster

228 PO-0092 Poster Tae-Kyu Jang South Korea Keimyung University Dongsan Medical Center 8. Rare Tumors including Uterine Sarcoma & GTD Giant uterine mass with uterine smooth muscle tumor of uncertain malignant potential: a case report Poster

230 PO-0093 Poster Lee Koichiro Japan Sakai city medical center 8. Rare Tumors including Uterine Sarcoma & GTD A case of squamous cell carcinoma of unknown primary site Poster

234 PO-0094 Poster Min-Hyun Baek South Korea Hallym University Sacred Heart Hospital 5. Epithelial Ovarian Cancer Impact of Metformin on Survival Outcome of Ovarian Cancer: A Nationwide Population Based Cohort Study Poster

239 PO-0095 Poster Koichi Ida JapanDepartment of Obstetrics and Gynecology, Shinshu

University School of Medicine9. Genetics

Effectiveness of a newly designed genetic panel containing 28 genes for gynecological cancers: An exploratory

studyPoster

244 PO-0096 Poster Yu Ka Chai Hong Kong Queen Mary Hospital 3. Pre-invasive Disease and Cancer of Vulvo-Vagina Vaginal Stripping for Vaginal Intraepithelial Neoplasia (VAIN) Poster

245 PO-0097 Poster Dong Choon Park South KoreaDept. of Biomedical Engineering, College of Medicine,

Kyung Hee University2. Pre-invasive Disease of Uterine Cervix New diagnostic device for cervical dysplasia using Electrical impedance imaging Poster

255 PO-0098 Poster You Wu ChinaNational center/cancer hospital, chinese academy of

medical sciences and peking union medical college4. Invasive Cervical Cancer

Value of adjuvant chemotherapy using paclitaxel plus carboplatin after radical surgery with or without

radiotherapy in stage IB-IIA cervical adenocarcinoma with risk factors.Poster

262 PO-0099 Poster Alexander Shushkevich Belarus N.N.Alexandrov Cancer Center of Belarus 7. Endometrial Hyperplasia, EIN and Endometrial Cancer The effect of lymph vessel invasion on the survival rate in low-risk endometrial cancer Poster

263 PO-0100 Poster Alexander Shushkevich Belarus N.N.Alexandrov Cancer Center of Belarus 7. Endometrial Hyperplasia, EIN and Endometrial Cancer Long-term results of high-risk stage I endometrial cancer depending on the morphological tumor type Poster

264 PO-0101 Poster Michele McColgan JapanSaitama Medical University International Medical

Center, Hidaka, Saitama14. Clinical trials, Trials in Progress

ENGOT-EN9/LEAP-001: a phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus

chemotherapy for first-line treatment of advanced or recurrent endometrial cancerPoster

266 PO-0102 Poster Reya Andrea Hurtado Philippines Philippine General Hospital 5. Epithelial Ovarian Cancer Rash and Ovarian Cancer: A Case of a Paraneoplastic Syndrome Poster

267 PO-0103 Poster Kyeong A So South KoreaDepartment of Obstetrics and Gynecology, Konkuk

University School of Medicine, Seoul5. Epithelial Ovarian Cancer Atypical endometriosis associated with ovarian malignancy Poster

268 PO-0104 Poster U Chul Ju South Korea Chonnam National University Medical School 7. Endometrial Hyperplasia, EIN and Endometrial Cancer Have type 1 and 2 endometrial cancers the different clinicopathological features and survival outcomes? Poster

269 PO-0105 Poster U Chul Ju South Korea Chonnam National University Medical School 7. Endometrial Hyperplasia, EIN and Endometrial CancerClinicopathological and survival analysis of synchronous primary endometrial and ovarian cancer: a single

institution review of 29 cases.Poster

276 PO-0106 Poster Sung Taek Park South Korea The Hallym University of Korea 13. Translational Research DDX53 confers the self-renewal and drug-resistance of ovarian cancer stem-like cells. Poster

279 PO-0107 Poster Kyeong A So South Korea

1Department of Obstetrics and Gynecology, Konkuk

University School of Medicine, Seoul, 2Cheil General

Hospital & Women's Healthcare Center, Seoul

2. Pre-invasive Disease of Uterine Cervix The impact of vaginal microbiota on the cervical carcinogenesis Poster

281 PO-0108 Poster Myeong Seon Kim South Korea

Department of Obstetrics and Gynecology, Samsung

Medical Center, Sungkyunkwan university school of

Medicine, Seoul, Korea.

4. Invasive Cervical Cancer Anti-tumor effects of Tetraarsenic oxide (TAO, As4O6) in human cervical cancer Poster

Page 17: ASGO 2019 Presentation Type for Abstracts …...ASGO 2019_Presentation Type for Abstracts Submitted by Oral Category Full Name Country Affiliation 1 OR-0001 Oral Presen ta ion Yuqin

Full Name Country Affiliation

Presentation TypeNo. Abstract No. Type

Author

Topic Title

282 PO-0109 Poster Hee Seung Kim South Korea Seoul National University College of Medicine 14. Clinical trials, Trials in ProgressReduction Of Cycles of neOadjuvant Chemotherapy for advanced epithelial Ovarian, fallopian or primary

peritoneal cancer (ROCOCO): study protocol for a phase III randomized controlled trialPoster

285 PO-0110 Poster Rattiya Phianpiset Thailand

Gynecologic Oncology Division, Department of

Obstetrics & Gynecology, Faculty of Medicine Siriraj

Hospital, Mahidol University, Bangkok, Thailand

2. Pre-invasive Disease of Uterine CervixThe American Society for Colposcopy and Cervical Pathology (ASCCP) 2017 risk-based colposcopy practice

recommendations when applied for Thai women with ASC-US or LSIL cervical cytology.Poster

286 PO-0111 Poster Young-Han Park South Korea Hallym University Medical Center 13. Translational Research The notch signaling change by catecholamine in epithelial ovarian cancer Poster

287 PO-0112 Poster Hyun Jung Lee South Korea Kyungpook National University,School of Medicine 15. Surgical Techniques Effectiveness of the bipolar vessel sealer in robot-assisted pelvic and infrarenal paraaortic lymphadenectomy. Poster

289 PO-0113 Poster Dong Hoon Suh South Korea Seoul National University Bundang Hospital 2. Pre-invasive Disease of Uterine Cervix Management of cervical intraepithelial neoplasia 2 in young women Poster

290 PO-0114 Poster Dong Hoon Suh South Korea Seoul National University Bundang Hospital 5. Epithelial Ovarian Cancer Oncologic safety of closed suction technique in removal of huge ovarian cyst Poster

296 PO-0115 Poster Yeni Kim South Korea

Department of Obstetrics and Gynaecology, University

of Ulsan College of Medicine, Asan Medical Center,

Seoul

8. Rare Tumors including Uterine Sarcoma & GTD Prediction of distant metastasis in patients with early ~ locally advanced uterine sarcoma Poster

297 PO-0116 Poster Zhiqin Fu China Zhejiang Provincial Hospital 5. Epithelial Ovarian Cancer A small subunit processome protein UTP23 reverses paclitaxel-resistance in ovarian cancer Poster

298 PO-0117 Poster Hao Lin Taiwan Kaohsiung Chang Gung Memorial Hospital 5. Epithelial Ovarian CancerImpact of the time interval between primary debulking surgery to adjuvant chemotherapy in advanced ovarian

cancerPoster

301 PO-0118 Poster Min Chul Choi South Korea

Comprehensive Gynecologic Cancer Center, CHA

Bundang Medical Center, CHA University, Seongnam-si,

Gyeonggi-do, Korea

11. Supportive CareThe feasibility of gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian

insufficiency in patient with malignant ovarian germ cell tumorsPoster

305 PO-0119 Poster Yen-Ling Lai TaiwanDepartment of Obstetrics and Gynecology, National

Taiwan University Hospital8. Rare Tumors including Uterine Sarcoma & GTD

Clear Cell Carcinoma of the Abdominal Wall as a Rare Complication of General Obstetric and Gynecologic

Surgeries: 15 Years of Experience at a Large Academic InstitutionPoster

306 PO-0120 Poster Cheng-Chang Chang Taiwan

Department of Obstetrics and Gynecology, Tri-Service

General Hospital, National Defense Medical Center,

Taipei, Taiwan

5. Epithelial Ovarian CancerCore Immunological Functions Involved in Ovarian Clear cell Carcinoma Discovered by the Gene Ontology-Based

Immunofunctionome AnalysisPoster

314 PO-0121 Poster Myeong Seon Kim South Korea

Department of Obstetrics and Gynecology, Samsung

Medical Center, Sungkyunkwan University School of

Medicine

9. GeneticsReal-World Experience of Pembrolizumab in Patients with Gynecologic malignancy: The First Reports of Republic

of Korea.Poster

318 PO-0122 Poster Hyun Park South Korea CHA University 4. Invasive Cervical CancerLong-term results of minimally invasive versus abdominal radical hysterectomy in patients with early cervical

cancerPoster

320 PO-0124 Poster Hijriah Anwar IndonesiaObstetric and Gynecology Department, Faculty of

Medicine, Hasanuddin University, Makassar, Indonesia4. Invasive Cervical Cancer

Incidence of tumor spreading to pelvic lymph nodes in early-stage cervical carcinoma that undergone radical

hysterectomy in Makassar during 2015-2017Poster

325 PO-0125 Poster ChulKwon Lim South Korea Asan medical center 11. Supportive Care Prevention of venous thromboembolism in gynecologic oncology surgery Poster

331 PO-0126 Poster Tiantian Wang ChinaCancer Hospital, Chinese Academy of Medical Sciences

and Peking Union Medical College5. Epithelial Ovarian Cancer Clinicopathologic features and prognostic analysis of stage I ovarian clear cell cancer Poster

343 PO-0127 Poster Seiya Sato Japan Iwate Medical University School of Medicine 4. Invasive Cervical Cancer Outcome of patients with uterine cervical cancer undergoing radical hysterectomy using the 2018 FIGO staging Poster

346 PO-0128 Poster Rikako Soma Japan Iwate Medical University 4. Invasive Cervical Cancer A case of primary signet ring cell carcinoma of the uterine cervix treated with CPT-11/S-1 therapy. Poster

347 PO-0129 Poster Tadahiro Shoji Japan Iwate Medical University School of Medicine 5. Epithelial Ovarian CancerA phase II study of irinotecan and pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian

cancer (Tohoku Gynecologic Cancer Unit 104 study)Poster

348 PO-0130 Poster Malika Kengsakul Thailand

Division of Gynecologic Oncology, Department of

Obstetrics and Gynecology, Faculty of Medicine,

Srinakharinwirot University, Panyananthapikhu

8. Rare Tumors including Uterine Sarcoma & GTD Intraoperative tumor lysis syndrome in a patient with advanced ovarian cancer Poster

349 PO-0131 Poster Jihye Kim South KoreaDepartments of Obstetrics and Gynecology, Dankook

University Hospital9. Genetics

Nation-wide analysis of clinical NGS panel for performing precision oncology for epithelial ovarian, peritoneal

and tubal cancer patient (KGOG 3047 study) ? Preliminary Analysis Reports of Retrospective studyPoster

Page 18: ASGO 2019 Presentation Type for Abstracts …...ASGO 2019_Presentation Type for Abstracts Submitted by Oral Category Full Name Country Affiliation 1 OR-0001 Oral Presen ta ion Yuqin

Full Name Country Affiliation

Presentation TypeNo. Abstract No. Type

Author

Topic Title

351 PO-0132 Poster Wu Xiaotong China Peking University People's Hospital 10. Quality of Life sexual quality following cervical cancer Poster

355 PO-0133 Poster Akihiko Ueda Japan Kyoto University Graduate School of Medicine 5. Epithelial Ovarian Cancer Olaparib maintenance therapy for the recurrent high-grade serous ovarian carcinoma: a single center experience Poster

358 PO-0134 Poster WHAN SHIN South Korea Severance Hospital, Yonsei University College of Medicine10. Quality of LifePeriumbilical Infiltration of Lidocaine with Epinephrine vs Bupivacaine for Postoperative Pain Reduction in Multi-

port Laparoscopic Adnexal Surgery.Poster

363 PO-0135 Poster Qi maili Singapore KK Women’s and Children’s Hospital 3. Pre-invasive Disease and Cancer of Vulvo-Vagina Experience of treatment of vulvar malignancies in a regional tertiary centre in Southeast Asia Poster

364 PO-0136 Poster Dan-ah chae South KoreaDepartment of Obstetrics and Gynecology, Chung-Ang

University Hospital2. Pre-invasive Disease of Uterine Cervix HPV Infection and p16 Promoter Methylation as Predictors of ASC-US/LSIL Progression Poster

365 PO-0137 Poster Daegy Hong South Korea Kyungpook National University 5. Epithelial Ovarian CancerTransmembrane G protein coupled receptor 30 (GPR30) gene polymorphisms in Korean Women with Ovarian

Cancer: An experimental studyPoster

366 PO-0138 Poster Hyun Jung Lee South Korea Kyungpook National University 4. Invasive Cervical CancerPrognostic value of the posttreatment high neutrophil-to-lymphocyte ratio in cervical cancer treated by

chemoradiotherapy.Poster

367 PO-0139 Poster Masae Yoo Japan OosakaMedicalCollege 12. Fertility Preservation Pregnancy outcome after MPA therapy Poster

368 PO-0140 Poster HeeKyoung Song South KoreaSeoul St. Mary's hospital, College of Medicine, The

Catholic University of Korea5. Epithelial Ovarian Cancer Circulating tumor DNA in epithelial ovarian cancer Poster

369 PO-0141 Poster JAEMAN BAE South Korea Hanyang University 10. Quality of Life Conditional Relative Survival of cervical cancer: Analysis of Korean Central Cancer Registry data Poster

370 PO-0142 Poster Kewalin Khumthong Thailand Faculty of Medicine Khon Kaen University 7. Endometrial Hyperplasia, EIN and Endometrial Cancer Association of abnormal Pap smear with occult cervical stromal invasion in patients with endometrial cancer Poster

371 PO-0143 Poster Eun Young Ki South Korea The Catholic university of Korea 1. Cancer ScreeningUtility of human papillomavirus L1 capsid protein and HPV test as prognostic markers for cervical intraepithelial

neoplasia 2+ in women with persistent ASCUS /LSIL cervical cytologyPoster

372 PO-0144 Poster KYUNGJOO CHO South Korea

Department of Obstetrics & Gynecology, Gil Medical

Center, College of Medicine, Gachon University,

Incheon, Republic of Korea

5. Epithelial Ovarian Cancer INHIBITION OF PTEN INDUCES ANTI-PROLIFERATIVE EFFECT ON OVARIAN CANCER CELLS. Poster

373 PO-0145 Poster SUNGYAO CHEN Taiwan Linkou Chang Gung Memorial Hospital 7. Endometrial Hyperplasia, EIN and Endometrial CancerPost-Operative Outcome of Sentinel Lymph Node Mapping in Early Stage Endometrial Cancer Staging Surgery:

A retrospective study and experience from a single centerPoster

374 PO-0146 Poster Bernadette Yap Philippines UP-Philippine General Hospital 7. Endometrial Hyperplasia, EIN and Endometrial CancerVaginal recurrence in Sentinel Lymph Node Biopsy-Negative Stage IA Endometrial Carcinoma using Near-

Infrared Fluorescence with Indocyanine Green DyePoster

375 PO-0147 Poster Chen Bin Chang Taiwan Chang Gung memorial hospital 5. Epithelial Ovarian Cancer The outlook of treatment of ovarian clear cell carcinoma (CCC) ? in molecular aspect Poster

376 PO-0148 Poster Risya Salimah Indonesia

Division of Gynecology-Oncology, Department of

Obstetrics and Gynecology, Faculty of Medicine,

Padjadjaran University / Dr. Hasan Sadikin General

8. Rare Tumors including Uterine Sarcoma & GTDIdentifying The Factors Affecting Chemotherapy Resistance of Single Agent Methotrexate in Gestational

Trophoblast Neoplasia (GTN) Low-Risk Stage I, II and III Therapy in Hasan Sadikin Hospital West JavaPoster

377 PO-0149 Poster Mi-Kyung Kim South Korea Ewha Womans University 1. Cancer ScreeningProfiling of serum metabolites using MALDI-TOF and Triple-TOF mass spectrometry to develop a screen for

ovarian cancerPoster

378 PO-0150 Poster Mi-Kyung Kim South Korea Ewha Womans University 13. Translational Research BET bromodomain proteins, BRD3 and BRD4, play a crucial role in ovarian cancer cell survival Poster

379 PO-0151 Poster Hsiujung Tung TaiwanDepartment of Obstetrics and Gynecology, Chang

Gung Memorial Hospital Linkou branch4. Invasive Cervical Cancer Pembrolizumab for unresectable recurrent cervical cancer - pilot experience in a tertiary center of Taiwan Poster

380 PO-0152 Poster Joo-Hyuk Son South Korea

Department of Obstetrics and Gynecology, Ajou

University School of Medicine, Suwon, Republic of

Korea

8. Rare Tumors including Uterine Sarcoma & GTDCytoreductive surgery and HIPEC for primary peritoneal anaplastic ependymoma with extensive peritoneal

carcinomatosisPoster

381 PO-0153 Poster Joo-Hyuk Son South Korea

Department of Obstetrics and Gynecology, Ajou

University School of Medicine, Suwon, Republic of

Korea

8. Rare Tumors including Uterine Sarcoma & GTD Cytoreductive surgery and HIPEC for intraabdominal synovial sarcoma with peritoneal carcinomatsois Poster

Page 19: ASGO 2019 Presentation Type for Abstracts …...ASGO 2019_Presentation Type for Abstracts Submitted by Oral Category Full Name Country Affiliation 1 OR-0001 Oral Presen ta ion Yuqin

Full Name Country Affiliation

Presentation TypeNo. Abstract No. Type

Author

Topic Title

382 PO-0154 Poster Emily D’Silva MalaysiaObstetrics and Gynecology Department, Ampang

Hospital8. Rare Tumors including Uterine Sarcoma & GTD Clear Cell Carcinoma in Disguise Poster

383 PO-0155 Poster SOMI OH South Korea Gangnam Kwon's Gynecology Clinics 5. Epithelial Ovarian Cancer Integration of plasma proteomics and targeted plasma metabolomics data for serous ovarian cancer diagnosis Poster

384 PO-0156 Poster Dwi Faradina Indonesia University of Sumatera Utara 3. Pre-invasive Disease and Cancer of Vulvo-Vagina Bartholin Gland Cancer Poster

385 PO-0157 Poster Jooyoung Kim South KoreaDepartment of Obstetrics and Gynecology, Seoul

National University Bundang Hospital, Seongnam10. Quality of Life Sexual dysfunction, symptomatic lymphedema and impaired global QOL are common in ovarian cancer survivors Poster

386 PO-0158 Poster Junsik Park South Korea

Department of Obstetrics and Gynecology, Institute of

Women’s Life Medical Science, Yonsei University

College of Medicine

5. Epithelial Ovarian CancerFeasibility of neoadjuvant chemotherapy containing bevacizumab and interval debulking surgery for advanced

epithelial ovarian cancer: preliminary dataPoster

387 PO-0159 Poster Syifa Syafitri Indonesia FMUI 4. Invasive Cervical CancerFive year survival rate after radiation of stage IIB-IIIB squamous cell cervical cancer patients and its relationship

with HPV infectionPoster

388 PO-0160 Poster Di Wu ChinaBeijing Obstetrics and Gynecology Hospital, Capital

Medical University10. Quality of Life

Downregulation of miR-214-3p in exosomes contributes to fibrosis as determined by primary endometrial cell

isolation from patients with Endometriosis and by endometrial cell line culture: The role of exosomes in the

horizontal transfer of miR-214-3p

Poster

389 PO-0161 Poster Kohei Omatsu Japan Cancer Institute Hospital 8. Rare Tumors including Uterine Sarcoma & GTDImmunohistochemical staining of PD-L1 and CD8+ T-cells in tumor tissue is a useful predictor of nivolumab

efficacy against mucosal melanomaPoster

390 PO-0162 Poster Jaein Kim South Korea Yonsei University College of Medicine 5. Epithelial Ovarian CancerIdentification of cancer-related long non-coding RNAs before and after neoadjuvant chemotherapy in epithelial

ovarian cancer.Poster

Page 20: ASGO 2019 Presentation Type for Abstracts …...ASGO 2019_Presentation Type for Abstracts Submitted by Oral Category Full Name Country Affiliation 1 OR-0001 Oral Presen ta ion Yuqin

1 Film-0001 Oral-Film Presentation Huaiwu Lu China Sun Yat-sen Memorial hospital 15. Surgical Techniques Laparoscopic radical hysterectomy without uterine manipulator for early stage cervical cancer Play

2 Film-0002 Oral-Film Presentation Hwajung Lee South Korea Ramathibodi hospital 15. Surgical Techniques Single-site endometrial cancer surgical staging The first experience with Da Vinci SP system Play

3 Film-0003 Oral-Film Presentation Libing Xiang China Fudan University Shanghai Cancer Center 15. Surgical Techniques Total pelvic peritonectomy for ovarian cancer with extensive peritoneal carcinomatosis in pelvic cavity Film Session

4 Film-0004 Oral-Film Presentation Seungmee Lee South KoreaDepartment of Obstetrics and Gynecology, School of

Medicine, Keimyung University15. Surgical Techniques Robot assisted triple-flap method for uterine adenomyosis followed by successful pregnancy Play

5 Film-0005 Oral-Film Presentation Yasuhiko Shiki Japan Osaka Rosai Hospital 15. Surgical Techniques Clinical anatomy required in identifying pelvic autonomic nerve system Film Session

6 Film-0006 Oral-Film Presentation Sang Wun Kim South Korea Yonsei University College of Medicine 15. Surgical Techniques Single-port laparoscopic radical trachelectomy with fluorescent image-guided sentinel lymph node dissection Film Session

7 Film-0007 Oral-Film Presentation Yoon Lee South Korea kyungpook national university chilgok hospital 15. Surgical TechniquesRobot assisted Extended Nerve Sparing Radical Hysterectomy with Extended Pelvic Lymphadenectomy for the

Cervical CancerPlay

8 Film-0008 Oral-Film Presentation Yoon Lee South Korea Kuyngpook national university Chilgok hospital 15. Surgical Techniques Prevention of Chylous ascites during the Robot assisted transperitoneal infrarenal paraaortic lymphadenectomy Film Session

9 Film-0009 Oral-Film Presentation Jeong Min Eom South Korea Hanyang University College of Medicine 5. Epithelial Ovarian Cancer Laparoscopic resection of bulky para-aortic lymph node metastasis Play

10 Film-0010 Oral-Film Presentation Jeong Min Eom South Korea Hanyang University College of Medicine 15. Surgical Techniques Laparoscopic primary repair of duodenal perforation after laparoscopic para-aortic lymphadenectomy Film Session

11 Film-0011 Oral-Film Presentation Sang Wun Kim South Korea Yonsei Cancer Center 15. Surgical Techniques Single-port Laparoscopic surgical staging in ovarian caner Play

12 Film-0012 Oral-Film Presentation Sang Wun Kim South Korea Yonsei Cancer Center 15. Surgical TechniquesLymphatic system of the uterus: Direct visualization by indocyanine green fluorescent image and fluorescence

image guided complete paraaortic lymphadenectomyPlay

14 Film-0014 Oral-Film Presentation May David Philippines N/A 10. Quality of LifeA Study on Contraceptive Knowledge, Attitude, and Practices Among Adolescent Gravidas in a Tertiary Hospital

in the PhilippinesPlay

15 Film-0015 Oral-Film Presentation Jung Hun LEE South Korea

Department of Obstetrics and Gynecology, Ewha

Womans University Seoul Hospital, College of

Medicine, Ewha Womans University

15. Surgical Techniques Robotic single-port surgical staging for endometrial cancer using da Vinci SP® surgical system Play

16 Film-0016 Oral-Film Presentation VANDANA JAIN India RGCIRC, DELHI 15. Surgical TechniquesRobotic radical Parameterectomy with bilateral pelvic node dissection for cervical cancer diagnosed after simple

hysterectomyPlay

17 Film-0017 Oral-Film Presentation RUPINDER SEKHON India RGCIRC, DELHI 15. Surgical Techniques Robotic anterior exenteration for recurrent cervical cancer Film Session

18 Film-0018 Oral-Film PresentationSupachai Raungkaewmanee Thailand Gynecologic oncology 15. Surgical Techniques LAPAROSCOPIC EXTRAPERITONEAL SYSTEMATIC PELVIC AND PARA-AORTIC LYMPHADENECTOMY Film Session

19 Film-0019 Oral-Film Presentation Zhengmao zhang China Fourth Hospital of Hebei Medical University 15. Surgical Techniques Cervical cancer surgery Play

20 Film-0020 Oral-Film Presentation rami khalifa Saudi Arabia asan 15. Surgical Techniquesnerve sparing modified laparoscopic radical hysterectomy with vaginal cuff closure and without uterine

manipulatorFilm Session

No. Abstract No. Type Author Topic Title Presentation Type

ASGO 2019_Presentation Type for Abstracts Submitted by Film Category

Page 21: ASGO 2019 Presentation Type for Abstracts …...ASGO 2019_Presentation Type for Abstracts Submitted by Oral Category Full Name Country Affiliation 1 OR-0001 Oral Presen ta ion Yuqin

No. Abstract No. Type Author Topic Title Presentation Type

21 Film-0021 Oral-Film Presentation Keun Ho Lee South Korea Seoul St. Mary's hospital 15. Surgical Techniques Single-site robotic staging surgery for early stage ovarian cancer Film Session

22 Film-0022 Oral-Film Presentation Yong-Wook Kim South Korea

Department of Obstetrics and Gynecology, Incheon St.

Mary's Hospital, College of Medicine, The Catholic

University of Korea

15. Surgical Techniques Single-port laparoscopic surgery for huge uterine mass using In-bag scalpel extraction Play

23 Film-0023 Oral-Film Presentation R RAJAGOPALAN R IndiaBASAVATARAKAM INDO AMERICAN CANCER

HOSPITAL AND RESEARCH INSTITUTE15. Surgical Techniques LAPAROSCOPIC RETROPERITONEAL LYMPHADENECTOMY -TRANSPERITONEAL APPROACH Play

24 Film-0024 Oral-Film Presentation Bo-Ra Lee South Korea Chung-Ang University Hospital 15. Surgical TechniquesCombined technique of single-site robot and laparoscopy in comprehensive staging operation of endometrial

cancerFilm Session

25 Film-0025 Oral-Film Presentation Hsin Mei Liu Taiwan FEMH 15. Surgical Techniques Laparoscopic ovarian cancer restaging for borderline tumor upgrade in laparotomy frozen section Play